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A B S T R A C T
Background
Accidental awareness during general anaesthesia (AAGA) is when a patient unintentionally becomes conscious during a procedure
performed with general anaesthesia and subsequently has explicit recall of this event. Incidence estimates for AAGA vary, with the most
common estimate being one to two cases per 1000 general anaesthetics. Evidence linking nitrous oxide use and an increased risk of
AAGA has come from observational studies data but the literature is contradictory, with some studies finding a protective effect of
nitrous oxide.
Objectives
To assess the effect of general anaesthesia including nitrous oxide on the risk of AAGA in patients aged five years and over.
Search methods
We searched the following databases: Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE and trial
registers ((www.clinicaltrials.gov), the WHO International Clinical Trials Registry Platform (www.who.int/ictrp/network/en/) and
CurrentControlledTrials (www.isrctn.com/)) for eligible studies onDecember 9 2015. In addition, we conducted forward and backward
citation searching using key identified papers.
Selection criteria
We considered all randomized controlled trials (RCTs), including quasi-randomized studies and cluster-randomized studies, of partic-
ipants aged five years or older receiving general anaesthesia for any type of surgery.
We included trials in which participants receiving general anaesthesia that included nitrous oxide for maintenance at a concentration
of at least 30% were compared with participants receiving no nitrous oxide during general anaesthesia. The intervention group must
have received nitrous oxide in conjunction with an additional anaesthetic. We excluded studies where the depth of anaesthesia differed
between the study arms. For inclusion in the review, studies needed to state in their methods that they planned to assess AAGA. We
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defined this as when a patient becomes conscious during a procedure performed with general anaesthesia and subsequently has explicit
recall of this event.
Data collection and analysis
We used standard methodological procedures expected by Cochrane to identify studies. We extracted data and conducted ’Risk of bias’
assessment using the Covidence database.
Main results
We included 15 studies. The total number of participants included in the analyses was 3520. Most studies were small with fewer than
120 participants, although two larger studies with 2012 and 671 participants were included. There was considerable variation in many
of the study characteristics, including the anaesthetics used. The concentrations of nitrous oxide varied between 50% and 70%, and
half of the studies used clinical signs and haemodynamic changes to monitor depth of anaesthesia.
As it was not possible to blind the anaesthetist to the anaesthetic used, we rated all studies at high risk of performance bias and we
therefore downgraded the quality of evidence by one level for risk of bias using the GRADE approach. Other types of bias were generally
low, or were rated unclear due to missing information.
No studies were designed to measure AAGA as the primary outcome, and were therefore statistically underpowered to answer this
review question. Despite the inclusion of 3520 participants, only three awareness events were reported by two studies. In one study the
event was due to technical failure. Due to the rarity of the events, we did not consider it appropriate to pool the data, and we therefore
downgraded the quality of evidence by a further level for imprecision using GRADE.
Authors’ conclusions
It is not possible to draw any conclusions from this review. The included studies were mainly small (fewer than 120 participants) and
there were limited estimates of effect, with only two studies reporting any events. We cannot therefore determine whether the use of
nitrous oxide in general anaesthesia increases, decreases or has no effect on the risk of accidental awareness.
P L A I N L A N G U A G E S U M M A R Y
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Review question
We reviewed the evidence about the effect of nitrous oxide used as part of a general anaesthesia on the risk of accidental awareness
during anaesthesia in people over the age of five years undergoing surgery.
Background
Accidental awareness during general anaesthetic is when a person accidentally becomes conscious during surgery, performed with
general anaesthesia, and can remember the event once they have woken up. Accidental awareness is an uncommon event, but it can be
extremely distressing for the patient and the doctors. There is some evidence suggesting that use of nitrous oxide may increase the risk
of accidental awareness. However, the literature is contradictory, with some studies finding no difference and others a decreased risk of
awareness in persons anaesthetized with nitrous oxide.
Search date
We searched for studies in December 2015.
Study characteristics and key results
We included 15 studies. The studies covered 3520 people. Although most studies were small with fewer than 120 participants, there
were two larger studies with 2012 and 671 participants included. There was a great variation in many of the important elements among
the studies, including the type of anaesthetics used and the levels of nitrous oxide used.
No study was designed to measure accidental awareness, but rather they measured it as a secondary outcome. Although there were
3520 participants included in the studies, there were only three reports of a participant becoming aware. These were reported in two
studies, and one was thought to be due to an error in the anaesthetic procedure.
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Nine studies reported where the funds for the research were obtained. Two were funded by pharmaceutical companies, suggesting a
potential bias, whereas five were funded through Universities or Government health research grants or a charity, limiting the risk of
bias. The remaining two studies reported that there was no conflict of interest, also reducing the risk of bias in these studies.
Quality of the evidence
Due to safety issues, all of the anaesthetists had to know what anaesthesia was being used. However, this means that the study results
may have been biased. Other indicators suggested a low risk of bias, or an unclear risk because of missing information. The quality of
the evidence is also low due to the lack of reports of a participant becoming aware.
Conclusions
It is not possible to draw any conclusions from this review. The included studies were mainly too small, and only two studies reported
any events. The review question is inadequately supported by the lack of strong evidence. The effect of nitrous oxide is hardly observed
due to the small sample size.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
What is the ef fect of general anaesthesia including nitrous oxide compared to without nitrous oxide on the risk of accidental awareness during general anaesthesia in pat ients
aged f ive years and over?
Patient or population: surgical pat ients
Sett ing: Seven studies in Europe, three in North America, two in Japan, one in India, one in Hong Kong and one internat ional mult i centred
Intervention: Nitrous oxide-based
Comparison: Nitrous oxide -f ree
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk without Nitrous
oxide
Risk with Nitrous oxide
Accidental awareness -
Overall (AAGA)
assessed with: Any
Study populat ion not est imable 3439
(14 RCTs)
⊕©©©
VERY LOW 12
Results not pooled due
to rarity of events
not pooled not pooled
Accidental awareness -
In recovery (AAGA)
assessed with: Any
Study populat ion not est imable 263
(5 RCTs)
⊕©©©
VERY LOW 12
Results not pooled due
to rarity of events
not pooled not pooled
Accidental awareness -
24 hours (AAGA)
assessed with: Any
follow-up: 1 days
Study populat ion not est imable 556
(7 RCTs)
⊕©©©
VERY LOW 12
Results not pooled due
to rarity of events
not pooled not pooled
* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI).
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
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1The anaesthet ist delivering the anaesthet ic was aware of the allocat ion in all studies, as this is essent ial for pat ient safety,
so we rated all studies at high risk of performance bias.
2Due to the rarity of the events no pooling was appropriate.
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B A C K G R O U N D
Description of the condition
Accidental awareness during general anaesthetic (AAGA) is when
a patient unintentionally becomes conscious during a procedure
performed with general anaesthesia and subsequently has explicit
recall of this event. The Michigan awareness classification instru-
ment (Mashour 2010) describes the features of awareness, which
range from no awareness through isolated auditory perceptions
to the experience of paralysis and pain. Awareness may be an ex-
tremely unpleasant experience and canhave serious long-term con-
sequences for patients.
Estimates of the incidence of long-term psychological problems in
patients who have experienced AAGA are variable (Lennmarken
2002; Samuelsson 2007) but have been as high as 71% (Leslie
2010). Explicit awareness requires consciousness (involving both
arousal and experience) and recall. Our limited understanding of
the underlying mechanisms of awareness and its risk factors reflect
current uncertainties inmodels for consciousness and formemory.
Incidence estimates for AAGA vary with the method of ascertain-
ment. The most widely used method, the Brice protocol (Brice
1970), involves asking the patient directly about dreams, recall
or other experiences between going to sleep and waking up. The
patients are asked these questions on three separate occasions over
a period postoperatively of up to 30 days. Most studies using
this method or a variation have found that possible or definite
awareness occurred in one to two cases per 1000 general anaes-
thetics (Avidan 2008; Avidan 2011; Mashour 2012; Myles 2004;
Sandin 2000; Sebel 2004; Wennervirta 2002). These estimates
are stable despite differences in study design (data from both ran-
domized controlled trials (RCTs) (Avidan 2008; Avidan 2011;
Mashour 2012; Myles 2004) and observational studies (Sandin
2000; Sebel 2004; Wennervirta 2002)); changes in number and
timing of interviews (interviews performed three times (Avidan
2008;Myles 2004; Sandin 2000), twice (Avidan 2011; Sebel 2004)
or only once (Wennervirta 2002)); and whether the study popu-
lation was unselected (Mashour 2012; Sandin 2000; Sebel 2004;
Wennervirta 2002) or considered at high risk of awareness (Avidan
2008; Avidan 2011; Myles 2004). Pooled data from five studies
in children reported an incidence of 7.4/1000 (Davidson 2011).
Pollard 2007 reported a much lower incidence of 1/14,500 cases
in adults. This study took place as part of quality assurance pro-
gramme and used a modified Brice questionnaire. Incidence es-
timates, based on surveys of anaesthetic staff reporting awareness
events that had been voluntarily reported by patients rather than
through a proactive questionnaire, are also much lower, 1/15,000
(Pandit 2013). The 5th National Audit Project (NAP5) was con-
ducted in the UK and Ireland during 2012 to 2013, and included
141 certain, probable or possible reports of AAGA arising from an
estimated approximately 3million general anaesthetics. This study
relied on spontaneous reports rather than direct questioning, and
estimated the incidence of certain/probable/possible awareness in
the UK as 1/19,600 (95% confidence interval (CI) 1/16,700 to
1/23,450) anaesthetics (Pandit 2014a; Pandit 2014b).
Risk factors for awareness are not well understood, but are likely
to be associated with an inadequate dose of the anaesthetic agent.
This may be intentional (due to clinical circumstance) or unin-
tentional (due to clinical error or unpredicted variation in patient
requirement). The incidence may be higher in women having a
caesarean section, with a recent estimate, based on only two cases,
of 2.6/1000 (Paech 2008). This increased risk may be due to a
lighter anaesthesia being given to reduce harm to the baby. There
is also evidence that cardiac cases are at higher risk of awareness
(Ghoneim 2009; Sebel 2004). Other risk factors may include fe-
male sex and younger age (Ghoneim 2009) and American Society
of Anesthesiologists (ASA) class III or IV (Sebel 2004), but data
are sparse and contradictory. Increased metabolism of the anaes-
thetic agent, due to genetic variation or induction of enzymes sys-
tems such as cytochrome P450 by alcohol or other drugs, may also
increase the risk of awareness (Mashour 2011). In NAP5 which
collected the largest ever cohort of cases of AAGA reported in one
study, factors increasing the risk of reports of accidental awareness
included female sex, age (younger adults but not children), obesity,
anaesthetist seniority (junior trainees), previous awareness, out-of-
hours operating, emergencies, type of surgery (obstetric, cardiac,
thoracic) and the use of neuromuscular blockade. ASA physical
status, race and use or omission of nitrous oxide were not risk
factors for reporting accidental awareness (Pandit 2014a; Pandit
2014b)
Studies of prevention of accidental awareness during
general anaesthesia (AAGA)
Some trials investigating awareness have focused on the use of in-
terventionswhichmay help to preventAAGA.These interventions
includemonitoring of brain activity andmonitoring of anaesthetic
concentrations or clinical signs that allow the patient’s level of con-
sciousness to be tracked.Monitoring of brain activitymay be based
on spontaneous electroencephalogram (EEG) activity or evoked
brain electrical activity, often auditory evoked potentials (AEP)
(ASA 2006). Bispectral index (BIS) monitors are used to assess
spontaneous EEG activity but trials of their use to prevent aware-
ness, compared to either routine care (Myles 2004; Zhang 2011)
or anaesthetic concentration monitoring (Avidan 2008; Mashour
2012), have given mixed results (Pandit 2013).
A Cochrane review (Punjasawadwong 2014), which was last up-
dated in 2014, reported a significant effect of BIS-guided anaes-
thesia in reducing the risk of awareness among surgical patients
considered at high risk of awareness, compared to using clinical
signs in the control groups (2493 participants; odds ratio (OR)
0.24, 95% CI 0.08 to 0.69). This effect was not demonstrated in
studies using anaesthetic concentration monitoring as the control
group (1981 participants; OR 1.01, 95% CI 0.14 to 7.16). An-
other meta-analysis (Shepherd 2013) demonstrated a significant
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reduction in awareness associated with BIS use (OR 0.45, 95%
CI 0.25 to 0.81), but highlighted the high heterogeneity between
studies. This meta-analysis did not include Mashour 2012, which
found no effect for BIS monitoring in a study population with no
increased risk of awareness where a protocol was used, but a reduc-
tion in awareness compared to ‘routine care’ without a protocol to
manage depth of anaesthesia. Guidance from the National Insti-
tute for Health and Clinical Excellence in the UK (NICE 2012)
recommended the use of BIS monitors as an option in patients at
high risk of awareness. It also concluded that although there was
greater uncertainty about the clinical benefit of other models of
EEG monitors, such as Narcotrend or Entropy, they should also
be considered as an option in patients at high risk of awareness.
Challenges when studying accidental awareness during
general anaesthesia
As AAGA is an uncommon event, RCTs are rarely large enough
to achieve statistical power. One RCT with 21,601 participants
enrolled was terminated due to inability to detect a difference in
the incidence of awareness between different anaesthetic proto-
cols (Mashour 2012). The use of non-randomized designs such
as case-control studies or analysis of routine data may offer the
potential for increasing power, but there are concerns about dif-
ferences other than nitrous oxide use between the intervention
and comparison groups which might bias the results of these stud-
ies. These potential confounders include depth of anaesthesia and
other risk factors for awareness, such as type of surgery and other
anaesthetic agents used. Meta-analysis can be useful in aggregat-
ing results across RCTs but it is important that the methods for
assessing awareness are comparable across studies and that the in-
tervention and comparison groups are equivalent for other risk
factors for AAGA. Studies which randomize participants to differ-
ent anaesthetic techniques, such as intravenous versus inhalational
and which include nitrous oxide in one arm only, are not suitable
for assessing the impact of nitrous oxide on AAGA.
Description of the intervention
Nitrous oxide gas has been used in general anaesthesia since its
early pioneering days. It is now commonly used with oxygen for
the maintenance of anaesthesia (Sury 2014). Such use has been
questioned due to the recognised side effects of nitrous oxide, in-
cluding the oxidation of vitamin B12 which results in the inhi-
bition of methionine synthesis and an increase in plasma homo-
cysteine levels for several days after surgery. This increase in ho-
mocysteine affects endothelial function, which has the potential
to destabilize atherosclerotic plaques (Leslie 2011). Nitrous oxide
is a weak anaesthetic and is insufficient to provide anaesthesia as
a single agent. It is typically used in the range of 50% to 70%
nitrous with oxygen 30% to 50% and either an additional volatile
anaesthetic agent or an intravenous infusion of anaesthetic. Its use
precludes very high inspired oxygen concentrations. Some studies
have found that high oxygen levels may improve wound healing
and reduce nausea and vomiting (Myles 2007). Evidence frompre-
vious RCTs suggest short- and long-term adverse effects of nitrous
oxide use during anaesthesia, including increased risk of postop-
erative nausea and vomiting, major complications within 30 days
(Myles 2007), and cardiovascular events up to five years after the
anaesthetic (Leslie 2011). However, two recent observational stud-
ies failed to find any association between nitrous oxide anaesthesia
and increased rates of mortality, one using routine data in an uns-
elected group (Turan 2013) and the second a post hoc analysis of a
trial of beta-blockers in participants at increased risk of cardiovas-
cular complications (Leslie 2013b). A recent large RCT designed
to explore the risks of nitrous oxide in major surgery found no
impact on mortality or cardiovascular morbidity but did find an
increase in severe nausea and vomiting (Myles 2014a). Two sys-
tematic reviews on the effects of nitrous oxide have recently been
published (Imberger 2014; Sun 2015). The Cochrane review (Sun
2015) investigated the differences in outcomes between nitrous
oxide-based and nitrous oxide-free general anaesthesia in adults
undergoing surgery. It concluded that “the avoidance of nitrous
oxide may be reasonable in participants with pre-existing poor
pulmonary function or at high risk of postoperative nausea and
vomiting”. The non-Cochrane review (Imberger 2014) looked at
the cardiovascular effects of nitrous oxide and concluded that there
was insufficient robust evidence to determine the effects.
How the intervention might work
Evidence linking nitrous oxide use with an increased risk of ex-
plicit awareness has come from observational studies data in both
adults (Errando 2008) and children (Davidson 2011), but the lit-
erature is contradictory, with some studies finding a protective
effect of nitrous oxide (Cook 2008; Rungreungvanich 2007). A
meta-analysis from 1996 of seven RCTs (Tramer 1996) reported a
decreased risk of awareness in participants anaesthetized with ni-
trous oxide (OR 4.5, 95%CI 1.1 to 18). The results of the Tramer
1996 review in respect of AAGA should be treated with caution,
as the review was designed to investigate the association between
nitrous oxide use and postoperative nausea and vomiting rather
than AAGA. This means that the literature search was restricted
to studies reporting on nausea and vomiting and other studies re-
porting an AAGA outcome may have been missed. In addition
the studies included in the Tramer 1996 were not all designed to
identify awareness (Lampe 1990; Sengupta 1988) and some com-
pared different anaesthetic techniques (Wrigley 1991).
Nitrous oxide acts predominately as a N-methyl-D-aspartate
(NMDA) antagonist whereas the majority of conventional anaes-
thetic agents are gamma-aminobutyric acid (GABA) agonists (De
Vasconcellos 2013). It is not clear why nitrous oxide use should af-
fect the risk of awareness. Hopkins 2005 suggests that nitrous ox-
ide may decrease the risk of AAGA compared to other anaesthetic
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agents due to more stable pharmacokinetics, so that clinicians are
able to better predict the actual dose received by the patient, and
because nitrous oxide is more potent at suppressing the memory
of a noxious stimulus than other inhalational anaesthetic agents,
but this observation was from animal studies (Alkire 2004). Ni-
trous oxide is now always used with other anaesthetic agents and
the combination effects are thought to be additive (although the
ENIGMA II trial did not find this; Myles 2014a). In practice this
may be difficult to ’titrate’ and there may be antagonism between
anaesthetic agents which act on GABA receptors and the anti-
nociceptive effects of nitrous oxide, which may increase the risk
of awareness (Sanders 2010). At present we do not know whether
nitrous oxide affects awareness due to a direct action on the brain,
alters the action of other anaesthetic agents to affect awareness, or
has no effect on awareness. The use of brain activitymonitors in pa-
tients anaesthetized using nitrous oxide is complex, since NMDA
antagonists suppress cortical EEG less than GABA-ergic agents.
It has been shown that BIS values do not change during nitrous
oxide sedation (Isik 2007). Using brain monitors to titrate nitrous
oxide-based anaesthesia may therefore lead to an increase in dose
and inappropriately deep anaesthesia (De Vasconcellos 2013).
Why it is important to do this review
Unintentional explicit awareness during surgery is extremely un-
pleasant and may have long-term consequences for the patient.
Another Cochrane review is considering anaesthetic interventions
for the prevention of awareness (Messina 2008), but this review
does not specifically evaluate nitrous oxide. The existing meta-
analysis of the association between nitrous oxide use and AAGA
(Tramer 1996) has limitations and should be updated.
There has been recent concern about the possible adverse conse-
quences of using nitrous oxide as an anaesthetic agent. As part of
the ongoing debate about its future use, it is important to clarify
the relationship between nitrous oxide and awareness and whether
its use increases or decreases the risk of unintentional awareness.
O B J E C T I V E S
To assess the effect of general anaesthesia including nitrous oxide
on the risk of AAGA in patients aged five years and over.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered all randomized controlled trials (RCTs) including
quasi-randomized studies and cluster-randomized studies.
Types of participants
We included trials of participants aged five years or more, receiving
general anaesthesia for any type of surgery.
Types of interventions
We included trials in which participants receiving general anaes-
thesia that included nitrous oxide for maintenance at a concen-
tration of at least 30% were compared with participants receiv-
ing no nitrous oxide during general anaesthesia. The intervention
group must have received nitrous oxide in conjunction with an
additional anaesthetic. This could have been another inhalation
anaesthetic (such as sevoflurane, enflurane or isoflurane) or intra-
venous anaesthetic (such as propofol). We excluded studies where
nitrous oxide was used as the sole maintenance anaesthetic, which
was an old technique that is no longer clinically relevant. We ex-
cluded studies where participants were randomized to different
anaesthetic techniques apart from the administration of nitrous
oxide, for example inhalation versus intravenous anaesthetic.
Since depth of anaesthesia will affect the likelihood of accidental
awareness, we excluded studies where the two arms had different
depths of anaesthetic. In order to assess these we used the reported
minimum alveolar concentration (MAC) in the published re-
ports. MAC is the concentration of the vapour in the lungs that
is needed to prevent movement in 50% of people in response to
surgical stimulus. MAC is used to compare the strengths, or po-
tency, of anaesthetic agents. We assumed that, broadly, MACs are
additive, and used this to determine whether the two intervention
arms had ’similar depth anaesthetics’.
In some studies of nitrous oxide (for example Myles 2004) the
other anaesthesia protocol was not specified but left to the discre-
tion of the anaesthetist. In these studies the intention of random-
izationwas nitrous oxide or not, but both the control and interven-
tion groups could contain a mixture of different techniques and
agents and presumably depth of anaesthesia. We included studies
of this design, as randomization should even out these differences.
The main analyses amalgamated all types of additional anaesthetic
agent. If we had had sufficient studies with outcome events we
would have undertaken subgroup analyses for different additional
anaesthetics, for example nitrous oxide in conjunction with other
volatile inhalation anaesthetic agents versus the volatile inhalation
agents alone, or nitrous oxide in conjunction with propofol versus
propofol alone. These two analytic strategies would have allowed
us to examine whether nitrous oxide affects the risk of explicit
awareness regardless of the additional anaesthetic used or whether
any effect is due to interaction with a particular class of anaesthetic
agent.
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Types of outcome measures
Primary outcomes
1. Accidental awareness during general anaesthesia (AAGA):
defined as when a patient becomes conscious during a procedure
performed with general anaesthesia and subsequently has explicit
recall of this event. The qualitative aspects of awareness may be
reported on a scale such as the Michigan awareness classification
instrument (Mashour 2010), and we included recall of any type
of event (auditory or tactile with or without distress, i.e. class 1
and above on the Michigan awareness instrument). Study
investigators may also classify any reports of awareness as
definite, probable or possible. Precise definitions vary between
studies (Mashour 2009; Sandin 2000) but definite events are
often those confirmed by attending personnel; probable events
are those that the investigators were convinced were real, but for
which no confirmation could be obtained; and possible cases
occur in patients who were unable to recall any event definitely
that would have been indicative of true awareness. For studies
which divide awareness in this way, we included probable and
definite awareness events only. We classified reported events with
a high probability of occurring before or after anaesthesia as no
awareness.
We included studies which used the Brice protocol (Brice 1970),
questions for ascertainment or those with other direct questioning
methods over a shorter period. We did not include studies which
relied on unsolicited self reports of awareness.
Secondary outcomes
There were no secondary outcomes for this review.
Search methods for identification of studies
Electronic searches
We searched for eligible trials in the following databases: Cochrane
Central Register of Controlled Trials (CENTRAL; 2015, issue
12) , MEDLINE (via Ovid) (from 1946 to the 8th December
2015) and EMBASE (via Ovid) (from 1974 to 8th December
2015). We applied the Cochrane highly sensitive filter for RCTs
in MEDLINE and EMBASE (Higgins 2011b).
We also searched
the following trial registers: www.clinicaltrials.gov, the WHO In-
ternational Clinical Trials Registry Platform (www.who.int/ictrp/
network/en/) and Current Controlled Trials (www.isrctn.com/)
for ongoing trials on 9th December 2015. Our search strategies
are presented in Appendix 1.
We included any publication that reported study data, including
abstracts, letters and articles. We did not place any restriction on
language of publication.
Searching other resources
We undertook forward citation on the key review article (Tramer
1996) and backward citation on Tramer 1996 and Schallner 2013
identified from the electronic resources using Scopus and Web of
Science on the 9th December 2015.
Data collection and analysis
Selection of studies
We collated the results of the searches and removed duplicates.
The selection of eligible articles took place in two stages.
Two out of three authors (JH, JG and AN) screened all titles and
abstracts to remove studies that were very unlikely to be eligible.
We piloted 100 titles before reviewing all titles in order to clar-
ify criteria for discarding articles at this stage. If no abstract was
available but the title was possibly relevant, we obtained the full
text of the article. Because many trials of nitrous oxide in general
anaesthesia are conducted with the purpose of assessing cardio-
vascular and other outcomes, we could not discard them at the
title/abstract stage, as it was possible that awareness had been in-
cluded as a secondary outcome but not included in the abstract.
We therefore reviewed all trials with eligible design, population,
intervention and comparison groups in full text.
When we had screened all titles and abstracts, two of the same
three authors reviewed the full texts of potentially relevant titles.
We used Covidence for this stage of the review, and recorded
the reasons for exclusion in Covidence. We piloted 10 papers,
after which the authors met to compare results and to standardize
their procedure and decision making as required. We then read all
potentially relevant papers. The Covidence programme compared
results and the authors met to discuss discrepancies. We referred
any differences that we could not resolve toTCor AS.We recorded
the numbers of papers retrieved and exclusions at each stage, with
reasons for those reviewed in full text, in a PRISMA flowchart
(Figure 1). We summarize the details of ineligible papers which
we reviewed in full text in the ’Characteristics of excluded studies’
table.
Data extraction and management
Two authors (JH and AN) extracted data from eligible studies
using Covidence, with the form template adapted as required (
Appendix 2; Appendix 3). We reviewed the template after data
from the first three papers had been entered, and modified it as
required. If there were duplicate publications from the same study,
we created a composite dataset from all the eligible publications.
We resolved disagreements by discussion and, if necessary, consul-
tation with TC or AS.
9Nitrous oxide-based versus nitrous oxide-free general anaesthesia and accidental awareness during general anaesthesia in surgical
patients (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Assessment of risk of bias in included studies
We used the Cochrane ’Risk of bias’ tool to assess the quality of
study design and extent of potential bias (Higgins 2011a). We
considered the following domains.
1. Random sequence generation
2. Allocation concealment
3. Blinding of participants and personnel
4. Blinding of outcome assessment
5. Incomplete outcome data
6. Selective reporting
7. Other potential sources of bias
Random sequence generation
We assessed studies as having a low risk of bias if the methods of
sequence generation were clearly stated and were truly random.
Where the information was unclear we assessed studies as being at
unclear risk of bias and where studies were not truly random, e.g.
alternating allocation, we assessed studies as being at high risk of
bias.
Allocation concealment
We assessed studies as having a low risk of bias if the methods of
allocation concealment were clearly stated and allocation was truly
concealed, e.g. sealed opaque envelopes. Where the information
was unclear, we assessed studies as being at unclear risk of bias and
where allocation was not concealed we assessed studies as being at
high risk of bias.
Blinding of participants and personnel (performance bias)
It was unlikely that any study would blind the anaesthetist to the
intervention, as this is essential for participant safety.We therefore
assessed all studies as being at high risk of performance bias.
Blinding of outcome assessment (detection bias)
We assessed detection bias as low risk if the paper stated that
assessors or participants, or both, were blinded; unclear risk of bias
if it was not possible to determine if participants and assessors were
blinded; and high risk of bias if the assessors or participants, or
both, were not blinded.
Incomplete outcome data (attrition bias)
We assessed studies as being at low risk of bias if there was low
(< 20%) attrition equivalent across groups and the reasons were
unlikely to be related to AAGA. We assessed studies as being at
unclear risk of bias if it was not possible to assess the level of
attrition across groups. We assessed groups with greater than 20%
attrition, and either differences between groups or reasons that
were related to AAGA, or both, as having a high risk of bias.
Selective reporting (reporting bias)
As this review only included studies that prespecified the outcome
in the Methods section of the paper, this bias was not relevant for
included studies.
Other sources of bias
Cluster designs may be used in this topic, with anaesthetist, oper-
ating theatre or hospital being the unit of randomization. For any
cluster-randomized trials that we included, we would have paid
particular attention to baseline characteristics of the participants
and the expertise of the anaesthetist. However we identified no
cluster-randomized trials.
We completed a ’Risk of bias’ table for each included study within
Covidence. For each outcome, we summarized the risk of bias
assessments for each domain in ’Risk of bias’ graphs and figures.
We then imported data entered into Covidence into ReviewMan-
ager 5 (RevMan 5.3) and two authors (AN and JH) checked them.
Measures of treatment effect
The single outcome in this review is a dichotomous outcome (oc-
currence of accidental awareness). For this dichotomous outcome
we entered total numbers andnumbers of definite awareness events
within each randomization group into RevMan 5.3 and calculated
odds ratios (ORs) with 95% confidence intervals (CIs). We aimed
to use Peto ORs as AAGA is a rare event and we anticipated that
event data would be sparse. We would have entered data as odds
or risk ratios (and used a general inverse variance model) if we
had been unable to extract or obtain the raw data of numbers of
definite awareness and total numbers from the study.
We used the Peto odds ratio for meta-analysis of dichotomous
outcomes as this method performs well when events are rare. The
Peto method uses a fixed-effect model but our final choice of a
fixed-effect or random-effects statistical model for any meta-anal-
ysis would have been influenced by the study characteristics such
as control anaesthetic agent and method of ascertainment
Unit of analysis issues
For any cluster-randomized trials included in the review, we
planned to extract data directly from the publication only if the
analysis used accounted for the cluster design with a method such
as multi-level modelling or generalized estimating equations. If
these adjustments were not made within the report, we planned to
undertake approximate analyses by recalculating standard errors
or sample sizes based on the design effect.We would have analysed
the resulting effect estimates and their standard errors using the
generic inverse variance method in RevMan. However we identi-
fied no cluster-randomized trials.
Four studies included more than two arms, with two different
anaesthetics combined with nitrous oxide. Where studies made
more than one comparison we included the study multiple times if
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all arms included separate groups. Where comparisons were made
with the same control groupwe split the control group and entered
both comparisons.
Dealing with missing data
We planned to perform sensitivity analyses to compare the effect
of complete-case analysis, the worst-case scenario, and last obser-
vation carried forward options on the results of individual studies
and any meta-analyses.
Assessment of heterogeneity
We expected that the findings may differ between studies included
in the review. This heterogeneity may be due to:
• method of ascertainment of awareness
• concentration of nitrous oxide used
• class of additional anaesthetics given, such as inhalational or
intravenous
• co-interventions such as premedications given
• age group
• type of surgery and other factors affecting underlying risk of
awareness
We would have assessed the degree of heterogeneity by visual in-
spection of forest plots and by examining the Chi² test for hetero-
geneity. Heterogeneity would have been quantified using the I²
statistic. We would have considered an I² statistical value of 50%
or more to represent substantial levels of heterogeneity, but this
value would have been interpreted in light of the size and direc-
tion of effects and the strength of the evidence for heterogene-
ity, based on the P value from the Chi² test (Higgins 2011b). If
we had detected substantial clinical, methodological or statistical
heterogeneity across included studies we would not have reported
pooled results from meta-analysis, but instead used a narrative
approach to data synthesis. Due to lack of studies reporting any
AAGA event, we were unable to pool any data.
Assessment of reporting biases
Weplanned to examine funnel plots to assess the potential for pub-
lication bias if we identified 10 ormore studies reporting events for
awareness.Wewouldhave used visual assessment supplemented by
Egger’s test for asymmetry(Egger 1997). Heterogeneity between
studies may lead to asymmetry and we would have considered this
possibility when reviewing the results.
Data synthesis
We planned meta-analysis if we had comparable effect measures
from more than one study and where measures of heterogeneity
indicated that pooling of results was appropriate. Initial analy-
ses would have included all studies and results would have been
pooled across all types of additional anaesthetic agent. An I² sta-
tistical value of more than 80% would argue against an overall
pooled estimate being presented. If we had found this degree of
heterogeneity we would have investigated the causes using sub-
group analyses as described above (Assessment of heterogeneity).
.
Subgroup analysis and investigation of heterogeneity
If we hadhad sufficient studieswith outcome eventswewould have
attempted subgroup analyses to investigate the potential sources
of heterogeneity described above (Assessment of heterogeneity).
• Method of ascertainment of awareness such as
questionnaire, differences in classification of definite or probable
events
• Class of additional anaesthetics given, such as nitrous oxide
in conjunction with other volatile inhalation anaesthetic agents
versus volatile inhalation agents alone, or nitrous oxide in
conjunction with propofol versus propofol alone
• Co-interventions such as premedications given
• Age group
• Type of surgery and underlying risk of awareness: high risk
population or unselected population
We would have used the I² statistic to assess the reduction in
heterogeneity when introducing subgroups.
Sensitivity analysis
We planned to undertake sensitivity analyses to explore the po-
tential impact of missing data as described in the section Dealing
with missing data. We would have carried out analyses stratified
by risk of bias, and explored the impact of model choice on the
results of any meta-analyses.
Summary of findings
We used the principles of the GRADE system to give an overall
assessment of the evidence relating to AAGA (Guyatt 2008).
The GRADE approach incorporates risk of bias, directness of ev-
idence, heterogeneity of the data, precision of effect estimates and
risk of publication bias to give an overall measure of how confident
we can be that our estimate of effect is correct. JH and JG in-
dependently used the GRADEpro software to create a ’Summary
of findings’ table for the outcome of AAGA. We discussed any
discrepancies and if necessary would have referred them to SL for
a final decision.
R E S U L T S
Description of studies
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Results of the search
Figure 1 summarizes the results of the searches.We retrieved 8976
records from the electronic databases and 226 from citation and
trial searches. After duplicates were removed using Endnote X7,
we screened 4539 records for inclusion. Of these, we selected 225
for full-text review. This identified 22 publications covering 15
studies for inclusion in the review. Of those excluded at full-text
review most met all the inclusion criteria but were not designed
to measure AAGA as a primary or secondary outcome.
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Figure 1. Study flow diagram
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Included studies
We included 15 studies reported in 22 publications: Aceto 2002;
Albertin 2005; Arellano 2000; Crawford 1998; Dedola 2008;
ENIGMA; Girardi 1994; Handa 2010; Handa Tsutsui 2007;
Heath 1996; Lindekaer 1995; Ngan Kee 2002; Singh 2011;
Sukhani 1994; Vanacker 1999. The total number of participants
included in the analyses was 3520. Details of the studies are re-
ported in the ’Characteristics of included studies’ table.
Only one study (Heath 1996) was conducted in the UK, although
one further multicentre study did include a UK site (ENIGMA).
Six studies were conducted in Europe (Aceto 2002; Albertin 2005;
Dedola 2008; Girardi 1994; Lindekaer 1995; Vanacker 1999),
four of which were conducted in Italy (Aceto 2002; Albertin 2005;
Dedola 2008; Girardi 1994). Three studies were conducted in
North America; two in Canada (Arellano 2000; Crawford 1998)
and one in the USA (Sukhani 1994). The remaining studies were
conducted in Japan (Handa 2010; Handa Tsutsui 2007), India
(Singh 2011) and Hong Kong (Ngan Kee 2002).
Six studies did not report how the study was funded (Aceto 2002;
Girardi 1994; Handa 2010; Heath 1996; Sukhani 1994; Vanacker
1999); two reported there were no conflicts of interest (Handa
Tsutsui 2007; Singh 2011) and four were funded by Universities
or Government health research grants (Albertin 2005; Dedola
2008; ENIGMA; Ngan Kee 2002). Two studies were funded by
pharmaceutical companies (Crawford 1998; Lindekaer 1995) and
one by a charity (Arellano 2000).
All but two studies included fewer than 120 participants in their
final analyses, with numbers ranging from 35 to 118. The remain-
ing two studies were much larger with Arellano 2000 including
617 participants and the ENIGMA study including 2012 partic-
ipants in their final analyses.
Population
All but three studies (Arellano 2000; Handa 2010; Heath 1996)
reported the mean age of participants, with all but one reporting
similar mean ages ranging from 30 to 56. The exception was
Crawford 1998, which included children aged three to 12 years
and reported a mean age of six years.
The proportion ofmale participants included in the studies varied,
with eight studies (Albertin 2005; Arellano 2000; Girardi 1994;
HandaTsutsui 2007;Heath 1996;NganKee2002; Sukhani 1994;
Vanacker 1999) only including female participants (due to the
gynaecological nature of the types of surgeries being carried out),
although Dedola 2008 did include male participants but 88% of
the study population was female. In comparison Lindekaer 1995
included 93% male participants.
Intervention and comparison
Eleven studies included a single comparison of an arm with ni-
trous oxide and an arm without nitrous oxide (Arellano 2000;
Crawford 1998; ENIGMA; Girardi 1994; Handa 2010; Handa
Tsutsui 2007; Heath 1996; Lindekaer 1995; Singh 2011; Sukhani
1994; Vanacker 1999) and four studies included more than one
comparison (Aceto 2002; Albertin 2005; Dedola 2008; Ngan Kee
2002).
Aceto 2002 included four arms: anaesthesia was maintained either
with sevoflurane plus or minus nitrous oxide (comparison one)
or with Isoflurane plus or minus nitrous oxide (comparison two).
As all arms were distinct groups, we included them as separate
comparisons in the analyses.
Albertin 2005 also included four arms, with the dose of remifen-
tanil differing between arms; sevoflurane plus remifentanil 3ng.ml
−1 with or without nitrous oxide and sevoflurane plus remifentanil
1ng.ml−1 with or without nitrous oxide. As all arms were distinct
groups, we included both of them as separate comparisons in the
analyses.
Likewise, Dedola 2008 included four arms with the dose of
remifentanil differing between arms. Desflurane was used: desflu-
rane plus remifentanil 3 ng.ml−1 with or without nitrous oxide
and desflurane plus remifentanil 1 ng.ml−1 with or without ni-
trous oxide. As all arms were distinct groups, we included both of
them as separate comparisons in the analyses.
Finally, Ngan Kee 2002 included three arms. All arms re-
ceived sevoflurane, but one arm received fraction-inspired oxygen
(FiO ) at 0.5, one arm FiO 0.7 and one arm no nitrous oxide.
As there was only one nitrous oxide-free arm the results for the
nitrous oxide-free arm were split into two groups between the two
comparisons and added to the analyses.
The anaesthetics used in the studies varied,with sevenusingpropo-
fol (Arellano 2000; Crawford 1998; Handa 2010; Handa Tsutsui
2007; Heath 1996; Lindekaer 1995; Sukhani 1994), three using
sevoflurane (Aceto 2002; Albertin 2005; Ngan Kee 2002), three
using isoflurane (Aceto 2002; Girardi 1994; Singh 2011) and two
using desflurane (Dedola 2008; Vanacker 1999). One study left
other anaesthetics to the discretion of anaesthetists (ENIGMA).
Concentrations of nitrous oxide used in the included studies var-
ied, with two studies using 50% (Handa Tsutsui 2007; Ngan
Kee 2002), four studies 60% (Albertin 2005; Dedola 2008;
Girardi 1994; Singh 2011), one study 65% (Arellano 2000),
one study 66% (Heath 1996), two studies 67% (Handa 2010;
Vanacker 1999) and five studies 70% (Crawford 1998; ENIGMA;
Lindekaer 1995; Ngan Kee 2002; Sukhani 1994).
The method of establishing depth of anaesthesia and/or equiv-
alence between the two groups (i.e. the monitoring method
used) also varied between the studies. Eight studies used clini-
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cal signs/haemodynamic changes (Arellano 2000; Crawford 1998;
ENIGMA; Girardi 1994; Handa 2010; Lindekaer 1995; Sukhani
1994; Vanacker 1999). Four studies delivered fixed concentrations
(Albertin 2005; Dedola 2008; Handa Tsutsui 2007; Ngan Kee
2002), two studies used clinical experience but with no criteria
stated (Heath 1996; Singh 2011), and three studies used EEG-
based monitoring, one as the sole monitor of anaesthetic depth
(Aceto 2002) and two in addition to other forms of monitoring
(ENIGMA; Girardi 1994).
Method of outcome assessment
To be eligible, studies had to outline in the Methods section that
they were going to measure AAGA. All studies reported results
for AAGA, although no studies had AAGA as a primary out-
come. One study (ENIGMA) used a recognized instrument (Brice
1970), and two studies used a modified Brice protocol (Aceto
2002; Singh 2011). A further two studies used a structured ques-
tionnaire (Girardi 1994; Handa 2010) and it was unclear what
method Sukhani 1994 used. All other studies “asked” or ques-
tioned participants.
The timing of assessment varied, with seven studies assess-
ing AAGA whilst participants were in recovery (Arellano 2000;
Crawford 1998; Girardi 1994; Handa Tsutsui 2007; Heath
1996; Sukhani 1994; Vanacker 1999) and 10 studies 24 hours
later (Aceto 2002; Albertin 2005; Arellano 2000; Dedola 2008;
ENIGMA; Girardi 1994; Handa 2010; Heath 1996; Ngan Kee
2002; Singh 2011). Lindekaer 1995 reported in the Methods that
AAGAwas assessed at discharge and in the Results section reported
the results for AAGA at two hours after anaesthesia.
Excluded studies
We excluded 188 papers after full-text review. Twenty were not of
the required design, nine had participants under five years of age,
28 had an ineligible intervention or comparison e.g. not general
anaesthetic or comparing different anaesthetics, one paper was
a conference proceeding (all abstracts were checked). The main
reason for studies being excluded (130 instances)was that although
they met all other inclusion criteria they did not state that AAGA
was a predetermined outcome.
After full-text review, we identified a further 15 papers, reporting
on 12 studies, as not meeting the inclusion criteria. Details of these
12 excluded studies (Chowdhury 2014; Goto 1997; Goto 1997a;
Inada 1999;Kang2013; ENIGMA-II; Liu 2014; Luginbuhl 2005;
Nakata 1999; Ochiai 1999; Rocca 2000; Ropcke 2001) are shown
in Characteristics of excluded studies. Of these 12 studies, six did
not include an intervention or comparator relevant to this review
(Goto 1997; Goto 1997a; Luginbuhl 2005; Nakata 1999; Ochiai
1999; Ropcke 2001), for five studies the depth of anaesthesia dif-
fered between study arms (Chowdhury 2014; Inada 1999; Kang
2013; Liu 2014; Rocca 2000) and two papers reported on the
ENIGMA II study (ENIGMA-II), which did not measure AAGA.
Studies awaiting classification
There are no studies awaiting classification.
Ongoing studies
There are no ongoing studies
Risk of bias in included studies
The results of the ’Risk of bias’ assessments are shown in Figure 2;
Figure 3 and described below.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
The methods of random sequence generation and allocation con-
cealment were generally poorly reported, with six studies failing
to report methods of randomization thoroughly enough to deter-
mine whether the sequence generation was truly random (Girardi
1994; Handa 2010; Heath 1996; Lindekaer 1995; Sukhani 1994;
Vanacker 1999). Where adequate information was reported we
rated all studies at low risk of bias (Aceto 2002; Albertin 2005;
Arellano 2000; Crawford 1998; Dedola 2008; ENIGMA; Handa
Tsutsui 2007; Ngan Kee 2002; Singh 2011). Allocation conceal-
ment was adequately described in only four studies (Arellano
2000; ENIGMA; Ngan Kee 2002; Vanacker 1999), and was un-
clear due to lack of information in the remaining studies (Aceto
2002; Albertin 2005; Crawford 1998;Dedola 2008;Girardi 1994;
Handa 2010; Handa Tsutsui 2007; Heath 1996; Lindekaer 1995;
Singh 2011; Sukhani 1994).
Blinding
Performance bias
The anaesthetist delivering the anaesthetic was aware of the allo-
cation in all studies, as this was essential for participant safety and
so we rated all studies at high risk of bias.
Detection bias
Seven studies (Aceto 2002; Arellano 2000; Crawford 1998;
ENIGMA; Heath 1996; Singh 2011; Sukhani 1994) stated that
the investigator asking about awareness was blinded to participant
allocation, but in the other eight studies this was unclear. Since
many studies did not use a standardized instrument to ask about
accidental awareness this was a potential source of bias. Further-
more as this was a self-reported outcome if the participants were
aware of their allocation this could be a source of detection bias.
However only four studies stated that the participant was blinded
to allocation, and for the other 11 studies this was unclear (Aceto
2002; ENIGMA;Ngan Kee 2002; Singh 2011). For studies where
the investigator was blind to group allocation we assessed studies
to be at a low risk of detection bias, and where it was unclear we
assessed studies to be at unclear risk. No studies stated that per-
sonnel or participants were not blinded, so we rated none of them
at high risk of bias.
Incomplete outcome data
Eight of the studies reported no participant attrition (Aceto 2002;
Girardi 1994;Handa 2010;Handa Tsutsui 2007; Lindekaer 1995;
Ngan Kee 2002; Sukhani 1994; Vanacker 1999), and three low
levels of attrition, i.e. less than 20% (Crawford 1998; Dedola
2008; ENIGMA). Two studies reported levels of attrition higher
than 20%. Arellano 2000 reported 59% attrition without any
reasons stated and was therefore assessed as high risk of bias. Singh
2011 reported 23.3% and 26.8% attrition for the nitrous oxide-
free and -based groups respectively. As these levels were similar
across groups and the reason for the missing data unrelated to
AAGA, we rated this study at low risk. We judged a further two
studies to be at unclear risk of bias, as it was not clear which groups,
if any, had missing data (Albertin 2005; Heath 1996).
Selective reporting
As this review only included studies that prespecified the outcome
in the Methods section of the paper, this bias was not relevant for
included studies.
Other potential sources of bias
We identified no other potential sources of bias.
Effects of interventions
See: Summary of findings for the main comparisonWhat is the
effect of general anaesthesia including nitrous oxide compared to
without nitrous oxide on the risk of accidental awareness during
general anaesthesia in patients aged five years and over?
See: Summary of findings for the main comparison.
Primary outcome one: Accidental awareness during general anaes-
thesia (AAGA): defined as when a patient becomes conscious dur-
ing a procedure performed with general anaesthesia and subse-
quently has explicit recall of this event.
Of the 15 included studies, one (Heath 1996) could not be in-
cluded in the analyses as the number of participants in each group
was not reported. The AAGA data for the remaining 14 studies are
shown inAnalysis 1.1. As discussed in the section Included studies/
interventions and comparisons, four studies included more than
one comparison and are therefore included in the analysis more
than once i.e. for each comparison (Aceto 2002; Albertin 2005;
Dedola 2008; Ngan Kee 2002).
Firstly, we consider the overall data, regardless of timing of the
assessment of AAGA.
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AAGA assessed at any time point
The results of 18 comparisons from the 14 studies (Aceto
2002; Albertin 2005; Arellano 2000; Crawford 1998; Dedola
2008; ENIGMA; Girardi 1994; Handa 2010; Handa Tsutsui
2007; Lindekaer 1995; Ngan Kee 2002; Singh 2011; Sukhani
1994; Vanacker 1999), involving 3439 participants, are shown in
Analysis 1.1.1. There were three AAGA events reported in the in-
cluded studies, all in the nitrous oxide-based group. There were
two events in the large ENIGMA study, resulting in an odds ra-
tio of 7.27 with wide 95% confidence intervals (95% CI 0.45 to
116.26). It was not possible to determine from the published pa-
per when the AAGA was assessed, i.e. in recovery or at 24 hours
postoperatively. The one event in Arellano 2000 was due to a tech-
nical anaesthesia failure rather than a pharmacological effect, and
if it had been appropriate to conduct sensitivity analyses we would
have done so excluding this study. However with only two studies
reporting any events, one of which was due to technical failure
(Arellano 2000), no pooling or meta-analysis was appropriate.
AAGA assessed in recovery.
Analysis 1.1.2 reports the result for AAGA assessed in recovery.
For the seven studies stating that AAGA was measured in recov-
ery (Arellano 2000; Crawford 1998; Girardi 1994; Handa Tsutsui
2007;Heath 1996; Sukhani 1994; Vanacker 1999), it was not pos-
sible to determine the time point of the results reported byArellano
2000, and Heath 1996 could not be included in the analysis as the
total numbers in each group were not reported. The remaining
five studies (Crawford 1998; Girardi 1994; Handa Tsutsui 2007;
Sukhani 1994; Vanacker 1999), included 263 participants and are
shown in the analysis. No events of AAGA were reported in either
group.
AAGA assessed 24 hours after the anaesthetic
Analysis 1.1.3 reports the results for AAGA assessed 24 hours after
the anaesthetic. Of the 10 studies (Aceto 2002; Albertin 2005;
Arellano 2000; Dedola 2008; ENIGMA; Girardi 1994; Handa
2010; Heath 1996; Ngan Kee 2002; Singh 2011) stating that
AAGA was measured at 24 hours after anaesthesia, seven studies
reporting on 11 comparisons are included in the analyses (Aceto
2002; Albertin 2005; Dedola 2008; Girardi 1994; Handa 2010;
Ngan Kee 2002; Singh 2011). Again, Arellano 2000 and Heath
1996 could not be included. It was also not possible to include
the ENIGMA study, as the timing of the reported outcomes was
unclear. None of the seven studies/11 comparisons included in
the analysis reported AAGA events (Aceto 2002; Albertin 2005;
Dedola 2008; Girardi 1994; Handa 2010; Ngan Kee 2002; Singh
2011).
As no pooling or meta-analysis was possible, we could not carry
out any of the planned subgroup analyses, investigation of hetero-
geneity, sensitivity analyses or investigation of publication bias.
Using GRADE, we downgraded the quality of the evidence by
one level (poor), due to concerns about the risk of bias, and by
two levels (very poor) due to concerns around imprecision.
D I S C U S S I O N
Summary of main results
We included 15 studies, which had randomized participants to
receive nitrous oxide or not as part of a general anaesthetic (Aceto
2002; Albertin 2005; Arellano 2000; Crawford 1998; Dedola
2008; ENIGMA; Girardi 1994; Handa 2010; Handa Tsutsui
2007; Heath 1996; Lindekaer 1995; Ngan Kee 2002; Singh 2011;
Sukhani 1994; Vanacker 1999). None of the included trials was
designed to measure awareness as a primary outcome, and all were
underpowered to study this outcome. Despite a total number of
3520 participants, only three awareness events were reported by
two studies (Arellano 2000; ENIGMA), and we considered pool-
ing of data to be inappropriate.
Overall completeness and applicability of
evidence
It is not possible to draw any conclusions from this review. The
included studies were mainly small (the majority with fewer than
120 participants) and there were limited estimates of effect, since
only two studies reported any events with one of these due to
technical failure.
Quality of the evidence
Due to safety concerns, no anaesthetists were blinded to the use
of nitrous oxide, so all studies had high risk of performance bias,
resulting in us downgrading the quality of the evidence by one
level in the Summary of findings for themain comparison. Studies
were not designed to measure awareness and were therefore under-
powered, resulting in us downgrading the quality of the evidence
by a further level for imprecision. Overall we judged the evidence
to be of very low quality. See Summary of findings for the main
comparison for details. Furthermore, the variety of the methods
used for assessment of recall in the included studies (Brice, mod-
ified Brice, ‘questioning’, etc.) as well as the timing of assessment
might have also added to the potential risk of bias.
Potential biases in the review process
We carried out a thorough search to identify all randomized stud-
ies of the use of nitrous oxide in general anaesthesia since 1994.
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Our inclusion criteria required that the accidental awareness out-
come was listed in the Methods section of the paper and that par-
ticipants were asked directly about awareness. We excluded 132
additional studies, which met the inclusion criteria for popula-
tion, intervention and comparison group, as awareness was not
reported as a predefined outcome. Some of these studies may have
included spontaneous reports of AAGAand could have potentially
contributed to the review. However, the inherent bias of relying on
spontaneous reports of an outcome and the very different means
of ascertainment of AAGA mean that these studies were not eligi-
ble for inclusion in the review.
We excluded studies where it was possible to determine that the
study arms had different depths of anaesthesia (Chowdhury 2014;
Inada 1999; Kang 2013; Kang 2014; Liu 2014; Rocca 2000).
However, some studies did not report sufficient details to deter-
mine whether the depths of anaesthesia were equivalent, and we
have not excluded these studies. This is a potential source of bias,
in that more poorly-reported trials are more likely to be included.
However, none of the trials excluded for differing depths of anaes-
thesia reported any events of AAGA, so including or excluding
them would not have changed the findings of the review. In as-
sessing whether depths of anaesthesia differed, we assumed that
MACs are broadly additive.
Agreements and disagreements with other
studies or reviews
As our review failed to find sufficient evidence to draw any conclu-
sions, it is not possible to agree or disagree with previous reviews.
The Tramer 1996 review, which is the only existing meta-analysis
of trials of the association between the use of nitrous oxide and
accidental awareness, reported an increased risk of awareness in
participants who did not receive nitrous oxide, with a calculated
number needed to treat to prevent one additional instance of ac-
cidental awareness of 46. However the Tramer 1996 review was
not designed to answer this question, but was rather designed to
investigate the association between nitrous oxide use and postop-
erative nausea and vomiting. The search was restricted to studies
reporting on nausea and vomiting, and there was no restriction by
type of anaesthetic (Tramer 1996). Other narrative reviews (De
Vasconcellos 2013; Ghoneim 2009; Hopkins 2005), have incor-
porated the findings of the Tramer review.
We are not aware of any other systematic reviews of accidental
awareness and nitrous oxide. However, a recent large observational
study (5th National Audit Project) did not find an association
between the use of nitrous oxide and accidental awareness (Pandit
2014a; Pandit 2014b).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We are unable to draw any implications for clinical practice from
the results of this review. We have not been able to confirm the
findings from the previous review (Tramer 1996), using more re-
cent trial data and a more inclusive search. We cannot determine
whether the use of nitrous oxide in general anaesthesia increases,
decreases or has no effect on the risk of AAGA.
Implications for research
The findings of this review have wider implications for the study
of rare outcomes and adverse events. Although meta-analysis has
the potential to increase power by amalgamating results, this is not
feasible if there are few or no events reported in the included trials.
Assuming an incidence of 1/500 patients receiving general anaes-
thesia and that nitrous oxide leads to a 50% increase in awareness,
a trial would need to have over 11,737 participants in each arm
to have 80% power to detect the increase at 5% significance level.
This would increase to 23,511 participants in each arm if the in-
cidence was assumed to be 1/1000. An RCT with almost 11,000
in each arm investigating the use of bispectral index (BIS) was
recently terminated due to futility, and no significant difference in
incidence between the arms could be detected (Mashour 2012).
If such studies were to be done, it may be advisable to focus on
higher-risk groups such as those undergoing lower segment Cae-
sarean section, cardiac surgery, or receiving neuromuscular block-
ing drugs or total intravenous anaesthesia (TIVA). However, it is
not clear that the costs involved would be justified. Without such
studies it is unlikely that any future meta-analyses would be able
to draw any implications for clinical practice.
Observational studies have the potential to address this issue and
the recently-published NAP5, which examined new reports of
AAGA arising from approximately threemillion general anaesthet-
ics (Pandit 2014a; Pandit 2014b), found no association between
awareness and nitrous oxide use. The lower overall incidence of
reports of awareness (1/19,600) reflects that ascertainment relied
on spontaneous report of accidental awareness but there is no rea-
son to assume that any association with nitrous oxide would be
distorted by under-reporting. The routine use of direct question-
ing in conjunction with routine data has the potential to provide
further data.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Aceto 2002
Methods Study design: Randomized controlled trial
Study grouping: Parallel group
Participants Baseline Characteristics
Nitrous oxide-free - A
Number randomized: 10
Number analysed: 10
Age (mean): 54 (50 ± 58)
% male: 50
Type of surgery: Laparoscopic cholecystectomy
Nitrous oxide-based - A
Number randomized: 10
Number analysed: 10
Age (mean): 49 (39 ± 59)
% male: 40
Type of surgery: Laparoscopic cholecystectomy
Nitrous oxide-free - B
Number randomized: 10
Number analysed: 10
Age (mean): 52 (47 ± 57)
% male: 40
Type of surgery: Laparoscopic cholecystectomy
Nitrous oxide-based - B
Number randomized: 10
Number analysed: 10
Age (mean): 50 (43 ± 57)
% male: 60
Type of surgery: Laparoscopic cholecystectomy
Included criteria: ASA I - II undergoing elective laparoscopic cholecystectomy, aged 18
- 70 yrs, Christians
Excluded criteria: History of neurological or mental disease and hearing impairment.
Patients having major haemodynamic changes (mean arterial pressure and heart rate)
greater than 15% compared with baseline values), and blood loss with acute anaemia as
a result of intraoperative surgical complications were also excluded
Interventions Intervention Characteristics
Nitrous oxide-free - A
Name: sevoflurane + air (FiO 40%)
Induction: Thiopental sodium (5 mg/kg), fentanyl (5 mcg/kg) and vecuronium bromide
(0.08 mg/kg)
Maintenance: sevoflurane + air (FiO 40%)
Recovery: NR
Other drugs used: Boluses of fentanyl (2 mcg/kg) and additional vecuronium according
to clinical necessity
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Aceto 2002 (Continued)
Premedication: None
Duration of anaesthesia (min): 91 (70 ± 112)
Nitrous oxide-based - A
Name: Sevoflurane + N O (60%) in air (FiO 40%)
Induction: Thiopental sodium (5 mg/kg), fentanyl (5 mcg/kg) and vecuronium bromide
(0.08 mg/kg)
Maintenance: Sevoflurane + N O (60%) in air (FiO 40%)
Recovery: NR
Other drugs used: Boluses of fentanyl (2 mcg/kg) and additional vecuronium according
to clinical necessity
Premedication: None
Duration of anaesthesia (min): 107 (89 ± 125)
Nitrous oxide-free - B
Name: isoflurane + air (FiO 40%)
Induction: Thiopental sodium (5 mg/kg), fentanyl (5 mcg/kg) and vecuronium bromide
(0.08 mg/kg)
Maintenance: Isoflurane + air (FiO 40%)
Recovery: NR
Other drugs used: Boluses of fentanyl (2 mcg/kg) and additional vecuronium according
to clinical necessity
Premedication: None
Duration of anaesthesia (min): 90 (65 ± 115)
Nitrous oxide-based - B
Name: Isoflurane + N O (60%) in air (FiO 40%)
Induction: Thiopental sodium (5 mg/kg), fentanyl (5 mcg/kg) and vecuronium bromide
(0.08 mg/kg)
Maintenance: isoflurane + N O (60%) in air (FiO 40%)
Recovery: NR
Other drugs used: Boluses of fentanyl (2 mcg/kg) and additional vecuronium according
to clinical necessity
Premedication: None
Duration of anaesthesia (min): 97 (78 ± 116)
Monitoring:
(ML-AERs) recorded before anaesthesia, at 1 MAC and 30 mins after awakening. The
concentration of anaesthetic, monitored with an anaesthetic-respiratory gas analyser,
was maintained at 1 MAC for at least 20 mins before the intraoperative recording of
MLAERs, 5 mins after surgical incision
Outcomes Accidental awareness
24 hrs after awakening participants were assessed for explicit and implicit memory.
Explicit memory was assessed with a recall test. Participants were asked about the last
thing they remembered before going to sleep; the first thing they remembered when
they woke up; and anything which happened in between, including sounds, dreams, and
imagination. (i.e. modified Brice questionnaire)
Other stimulation during surgery
One of 4 audiotapes was played immediately after completion of MLAER recording.
Each audiotape contained 1 of the following stories: (i) The fox and the grapes; (ii) Jesus’s
birth; (iii) The prodigal son; and (iv) The miracle of the loaves and fishes. At the end
of each of the stories, 4 key words had been recorded. Recall of relevant words in these
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Aceto 2002 (Continued)
stories used to detect implicit recall
Identification Country: Italy
Setting: Department of Anaesthesiology and Intensive Care
Authors name: P Aceto
Institution: Catholic University of the Sacred Heart
Email: gdecosmo@rm.unicatt.it
Address:Department of Anaesthesiology and Intensive Care, Policlinico A. Gemelli, L.
go A. Gemelli 8,I-00168 Rome, Italy
Aim of study The aim of this study was to investigate the presence of subconscious awareness during
anaesthesia and to examine its relationship to the ML-AERs
Notes Sponsorship source: No details given
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “using randomization tables”
Allocation concealment (selection bias) Unclear risk Comment: No details reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “The patients were blinded to the
method of anaesthesia used and to the con-
tents of the tape (they were not told that
there would be a story on the tape).”
Comment: Participants were blinded, as
was the anaesthetist playing the tapes. No
mention of the anaesthetist giving the
anaesthesia, presumably not
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “The anaesthesia resident that con-
ducted the post- operative interview did
not know which anaesthetic had been used
or which story had been played.”
Comment: Outcome assessor and partici-
pants were blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: No losses to follow-up reported
Selective reporting (reporting bias) Low risk Comment: All relevant outcomes specified
in Methods reported
Other bias Low risk Comment: None identified
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Albertin 2005
Methods Study design: Randomized controlled trial
Study grouping: Parallel group
Participants Baseline Characteristics
Nitrous oxide-free -A
Number randomized: NR
Number analysed: 23
Age (mean): 40 (± 8)
% male: 0
Type of surgery: Elective abdominal surgery requiring skin incision
Nitrous oxide-free -B
Number randomized: NR
Number analysed: 30
Age (mean): 39 (± 7)
% male: 0
Type of surgery: Elective abdominal surgery requiring skin incision
Nitrous oxide-based -B
Number randomized: NR
Number analysed: 27
Age (mean): 38 (± 7)
% male: 0
Type of surgery: Elective abdominal surgery requiring skin incision
Nitrous oxide-based -A
Number randomized: NR
Number analysed: 22
Age (mean): 36 (± 8)
% male: 0
Type of surgery: Elective abdominal surgery requiring skin incision
Included criteria:
Women, aged 20 - 50 yrs, ASA I, scheduled for elective abdominal surgery requiring
skin incision
Excluded criteria:
Patients undergoing laparoscopic procedures, obesity (BMI 30 kg/m²), history of car-
diac, pulmonary or renal diseases, drug or alcohol abuse, or current use of any medica-
tions affecting the cardiovascular system or blocking the adrenergic responses to surgical
incision
Interventions Intervention Characteristics
Nitrous oxide-free -A
Name: Nitrous oxide-free remifentanil 3 ng/ml
Induction: IV propofol (2 mg/kg) and TCI remifentanil 4 ng/ml for intubation
Maintenance: Sevoflurane combined with oxygen and air FiO 40%, TCI remifentanil
3 ng/ml
Recovery: NR
Other drugs used: NR
Premedication: None used
Duration of anaesthesia (min): NR
Nitrous oxide-free -B
Name: Nitrous oxide-free remifentanil 1 ng/ml
Induction: IV propofol (2 mg/kg) and TCI remifentanil 4 ng/ml for intubation
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Albertin 2005 (Continued)
Maintenance: Sevoflurane combined with oxygen and air FiO 40% TCI remifentanil
3 ng/ml
Recovery: NR
Other drugs used: NR
Premedication: None used
Duration of anaesthesia (min): NR
Nitrous oxide-based -B
Name: Nitrous oxide-based remifentanil 1 ng/ml
Induction: IV propofol (2 mg/kg) and TCI remifentanil 4 ng/ml for intubation
Maintenance: Sevoflurane combined with 60% N O in oxygen, TCI remifentanil 1 ng/
ml
Recovery: NR
Other drugs used: NR
Premedication: None used
Duration of anaesthesia (min): NR
Nitrous oxide -based -A
Name: Nitrous oxide-based remifentanil 3 ng/ml
Induction: IV propofol (2mg/kg) and TCI remifentanil 4ng/ml for intubation
Maintenance: Sevoflurane combined with 60% N2O in oxygen, TCI remifentanil 3ng/
ml
Recovery: NR
Other drugs used: NR
Premedication: None used
Duration of anaesthesia (min): NR
Monitoring
The remifentanil infusion was set at the desired concentration ensuring an adequate
equilibration time between plasma and effect site (based upon the very short equilibration
time between plasma and effect site (KeO)). An up/down technique was then used to
determine the MAC of sevoflurane. The first participant assigned to all groups received
1.5MACof sevoflurane adjusted for age (3%) . The subsequent participant then received
a variable dose of sevoflurane (decreased or increased by 0.25MAC (0.5%)) according to
whether the preceding participant had responded (increase in heart rate of blood pressure
by 15% or not after surgical incision). After 3 sequential negative deflections the change
in MAC for each up/down response was reduced to 0.1 MAC (0.2%)
Outcomes • Accidental awareness
On the first postoperative day visit participants were questioned about any recall of
intraoperative events
Identification Country: Italy
Setting: NR
Authors name: Andrea Albertin
Institution: Vita-Salute University of Milano
Email: albertin.andrea@hsr.it
Address:Department of Anesthesiology, IRCCSH, San Raffaele, Vita-Salute University
of Milano, Via Olgettina 60, 20132 Milan, Italy
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Albertin 2005 (Continued)
Aim of study To determine the effects of adding nitrous oxide on sevoflurane requirement for blunting
sympathetic responses after surgical incision combined with 2 different target-controlled
concentrations of remifentanil (1 and 3 ng/ml) in women
Notes Depth of anaesthesia would not be equivalent in nitrous vs nitrous-free - at induction
(before MAC monitoring)
Lack of clarity on numbers studied: “102 female patients..... were prospectively enrolled”
but “A total of 102 female patients completed the study” and “Three patients in Group
N3 and one patient in Group A1 were withdrawn from the study for hypotension
requiring vasoactive agents.”
Sponsorship source: This study was supported by the Vita-Salute University of Milano
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “computer-generated sequence of
numbers,”
Comment: No further details
Allocation concealment (selection bias) Unclear risk Comment: No details given
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “anaesthesiologist recording cardio-
vascular parameters and determining the
positive-negative response to surgical inci-
sion was blinded to patient grouping.”
Comment: Anaesthetist giving anaesthetic
not blinded. Study described as double-
blind but no details of participant blinding.
Anaesthetist delivering anaesthetic presum-
ably not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Comment: Not reported as to whether the
outcome assessor for awareness was blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: Unclear as to whether 102 par-
ticipants were randomized or analysed; 3
withdrawals stated but whether they were
included in the final analysis is unclear
Selective reporting (reporting bias) Low risk Comment: All relevant outcomes described
in Methods were reported
Other bias Low risk Comment: None identified
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Arellano 2000
Methods Study design: Randomized controlled trial
Study grouping: Parallel group
Participants Baseline Characteristics
Nitrous oxide-free - A
Number randomized: 740
Number analysed: 310
Age (mean): NR for subsample with outcome
% male: 0
Type of surgery: Outcome data - 231 terminations of pregnancy: 79 laparoscopy
Nitrous oxide-based - A
Number randomized: 750
Number analysed: 307
Age (mean): NR for subsample with outcome
% male: 0
Type of surgery: Outcome data - 235 terminations of pregnancy: 72 laparoscopy
Included criteria:Women undergoing termination of pregnancy (TOP) or ambulatory
gynaecologic laparoscopy (LAP). ASA status I or II, between 18 and 55 yrs of age, all
day-surgery patients
Excluded criteria: Patients undergoing other ambulatory gynaecologic procedures were
not studied, to reduce heterogeneity in study population; history of psychiatric disease,
narcotic/sedative use, drug abuse, or morbid obesity (30% above ideal body weight)
Interventions Intervention Characteristics
Nitrous oxide-free - A
Name: Propofol + 100% O
Induction:
TOP: IV fentanyl 0.7 mcg/kg. 20 mg lidocaine and 2.0 mg/kg propofol IV over 40 secs,
further propofol titrated to loss of lid reflex
LAP: Fentanyl 1.5 mcg/kg and d-tubocurare 3 mg IV. 20 mg lidocaine and 2.0 mg/kg
propofol IV over 40 secs, further propofol titrated to loss of lid reflex. Succinylcholine
1.5 mg/kg IV, oral intubation. After induction, 0.075 - 0.1 mg/kg vecuronium IV
Maintenance:
TOP: 100% O . Intermittent bolus doses of 20 mg propofol in response to clinical
signs of light anaesthesia (movement, laccrymation, or phonation in response to surgical
stimuli, or increases in blood pressure, pulse rate, or respiratory rate of ≥ 20%)
LAP: 100% O . Infusion of propofol 100 - 200 mcg/kg/min supplemented by inter-
mittent bolus doses of 20 mg propofol in response to clinical signs of light anaesthesia
(movement, laccrymation in response to surgical stimuli or increases in blood pressure,
or pulse rate of ≥20%)
Recovery: At the end of surgery, neuromuscular blockade was reversed with atropine 0.
02 mg/kg and neostigmine 0.04 mg/kg. In all participants, propofol and N O were
discontinued when the dressing was applied at the end of surgery
Other drugs used: NR
Premedication: No premedication was given
Duration of anaesthesia (min): NR
Nitrous oxide-based - A
Name: Propofol + 65% N O
Induction:
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Arellano 2000 (Continued)
TOP: Fentanyl 0.7 mcg/kg IV. 20 mg lidocaine and 2.0 mg/kg propofol IV over 40 secs,
further increments of propofol titrated to loss of lid reflex
LAP: Fentanyl 1.5 mcg/kg and d-tubocurare 3 mg IV. 20 mg lidocaine and 2.0 mg/kg
propofol IV over 40 secs, further increments of propofol titrated to loss of lid reflex.
Succinylcholine 1.5 mg/kg IV and oral intubation. After induction, 0.075 - 0.1 mg/kg
vecuronium IV
Maintenance:
TOP: N O and O FiO 35% administered by mask. Intermittent bolus doses of 20
mg propofol in response to clinical signs of light anaesthesia (movement, laccrymation,
or phonation in response to surgical stimuli, or increases in blood pressure, pulse rate,
or respiratory rate of ≥ 20%)
LAP: N O and O FiO 35%. Anaesthesia maintained with an infusion of propofol
100 - 200 mcg/kg/min supplemented by intermittent bolus doses of 20 mg propofol in
response to clinical signs of light anaesthesia (movement or laccrymation in response to
surgical stimuli or increases in blood pressure, or pulse rate of ≥ 20%)
Recovery: At the end of surgery, neuromuscular blockade was reversed with atropine 0.
02 mg/kg and neostigmine 0.04 mg/kg. In all participants, propofol and N O were
discontinued when the dressing was applied at the end of surgery
Other drugs used: NR
Premedication: No premedication was given
Duration of anaesthesia (min): NR
Monitoring: Clinical signs as described above
Outcomes Accidental awareness
The incidence of perioperative dreaming and awareness during anaesthesia was assessed
in 649 participants 1 hr and 24 hrs after surgery, face-to-face or telephone interview
using a questionnaire. No reason given why only in subsample and not clear whether
based on 1- or 24-hr interview
Only 1 participant in this study reported intraoperative awareness (laparoscopy, N O
group). The attending anaesthesiologist noted that “this event was likely caused by a
kinked IV line that interrupted the flow of propofol for a short period”
Identification Country: Canada
Setting: 4 hospitals in Ontario
Authors name: Ramiro J. Arellano
Institution: Department of Anesthesia, University of Toronto
Email: arellano@is.dal.ca
Address:Department of Anesthesia,Queen Elizabeth II Health Sciences Center, Halifax
Infirmary, 1796 Summer Street, Halifax, Nova Scotia, Canada, B3H 3A7
Aim of study This study in women undergoing ambulatory gynaecologic surgery compares outcomes
in participants administered total intravenous anaesthesiawith propofol versus the propo-
fol plus N O. The primary outcome was the time to home readiness. Secondary out-
comes included the incidence of postanaesthetic adverse events
Notes “Six hundred forty-nine patients were questioned postoperatively about perioperative
dreams.” Numbers in relevant table (table 5 of paper) do not add up to 649 for either 1-
hr or 24-hr column. We have used the 24-hr column numbers. Numbers randomized:
propofol: 497 TOP: 243 lap; propofol +N O 503 TOP: 247 lap
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Arellano 2000 (Continued)
Sponsorship source: Supported by a grant from Physicians Services Incorporated Foun-
dation, Toronto, Ontario, Canada
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “randomly allocated by computer-
generated random numbers in blocks of
four to receive either total intravenous
anesthesia with propofol (TIVA group) or
propofol and N O (N O group). Strati-
cation by hospital site and surgical proce-
dure ensured that roughly equal numbers
of subjects within both treatment groups
were enrolled at each site”
Allocation concealment (selection bias) Low risk Quote: “Patients were allocated to either
the TIVA or N O group when the anes-
thesiologist opened the sealed opaque en-
velopes at induction of anesthesia”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “anesthesiologists were not blinded
to treatment allocation to ensure safe anes-
thetic care. Biased administration of the
anesthetics and unblinding of the research
assistants were prevented by the following:
(1) pre-enrollment training of anesthesiol-
ogists to standardize anesthetic administra-
tion; (2) random visits by the principal in-
vestigator to discuss the anesthetic proto-
col with the anesthesiologists; (3) ongoing
review of the anesthetic study sheets by the
principal investigator; (4) restricting the re-
search assistants from access to the operat-
ing rooms or patients’ charts”
Comment: No mention of participant
blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “Four research assistants blinded to
treatment allocation enrolled patients into
the study, obtained demographic and base-
line information, and collected postopera-
tive data”
Comment: No mention of participant
blinding
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Arellano 2000 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “Six hundred forty-nine patients
were questionedpost- operatively about pe-
rioperative dreams”
Comment: Only 617/1490 participants
had outcome data. No reason given
Selective reporting (reporting bias) Low risk Comment: All relevant outcomes described
in Methods reported
Other bias Low risk Comment: None identified
Crawford 1998
Methods Study design: Randomized controlled trial
Study grouping: Parallel group
Participants Baseline Characteristics
Nitrous oxide-free - A
Number randomized: NR
Number analysed: 18
Age (mean): 6.7 (± 2.5)
% male: NR
Type of surgery: Minor orthopaedic, urological and general surgical
Nitrous oxide-based - A
Number randomized: NR
Number analysed: 17
Age (mean): 6.2 (± 2.2)
% male: NR
Type of surgery: Minor orthopaedic, urological and general surgical
Included criteria: Age 3 - 12 ys, outpatient surgery lasting approximately 1 hr
Excluded criteria: Children excluded if they had a history of cardiorespiratory, gastroin-
testinal or CNS disease or if they requested premedication or inhalational induction
Interventions Intervention Characteristics
Nitrous oxide-free - A
Name: Propofol
Induction: Lignocaine 0.1 mg/kg vecuronium 0.15 mg/kg propofol 3 mg/kg
Maintenance: Propofol infusion with oxygen 30% in air. Initial infusion rate of propofol
was 300 mcg/kg. Titrated to keepHR and BP within 20% of baseline values.Maintained
above min of 50 mcg/kg with bolus of 25% of induction dose and infusion increased
by 25% if tachycardia or BP increased. Max infusion rate 300 mcg/kg. If signs of light
anaesthesia persisted - fentanyl 2 mcg/kg. Mean infusion rate 220 (± 37) and median 1
bolus (range 0 - 2)
Recovery: Neostigmine 50 mcg/kg and atropine 25 mcg/kg. All anaesthetic drugs discon-
tinued
Other drugs used: NR
Premedication: None
Duration of surg/anaes (mins): 55 (± 21) /83(±33)
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Crawford 1998 (Continued)
Nitrous oxide-based - A
Name: Propofol plus N O
Induction: Lignocaine 0.1 mg/kg vecuronium 0.15 mg/kg propofol 3 mg/kg
Maintenance: Propofol infusion with N O 70% in oxygen. Initial infusion rate 00 mcg/
kg. Titrated to keep HR and BP within 20% of baseline values. Maintained above min
of 50 mcg/kg with bolus of 25% of induction dose and infusion increased by 25% if
tachycardia or BP increased. Max infusion rate 300 mcg/kg. If signs of light anaesthesia
persisted fentanyl 2 mcg/kg. Mean infusion rate 180 (± 39) and median 0 bolus
Recovery: Neostigmine 50 mcg/kg and atropine 25 mcg/kg. All anaesthetic drugs discon-
tinued
Other drugs used: NR
Premedication: None
Duration of surg/anaes (mins): 47 (± 35)/69 (± 40)
Monitoring: Infusion rate of propofol was titrated to maintain heart rate and systolic
arterial pressure to within 20% of baseline values
Outcomes Accidental awareness
Before discharge fromPACU children asked if they had any recall of intraoperative events
Identification Country: Canada
Setting: Hospital for Sick Children, University of Toronto
Authors name: Jerrold Lerman
Institution: Hospital for Sick Children, University of Toronto
Email: NR
Address: J. Lerman, Dept of Anaesthesia, Hospital for Sick Children, 555 University
Ave, Toronto
Aim of study The present study examined the effect of nitrous oxide on the recovery characteristics of
propofol anaesthesia, and compared these data with those for halothane/nitrous oxide
anaesthesia
Notes A further group of 19 participants received halathone plus N O
60 children randomized; 6 were excluded when converted to regional anaesthesia after
induction. Not reported from which group
Sponsorship source: Study supported in part by a grant from ICI Pharma Ltd
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “assigned using a table of random
numbers”
Allocation concealment (selection bias) Unclear risk Comment: No details given
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: Anaesthetist giving anaesthetic
not blinded. Clear criteria for adjusting the
depth of anaesthetic. No mention of par-
ticipant blinding
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Crawford 1998 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “Postoperative data were gathered
by an investigator who was unaware of the
anaesthetic regimen administered”
Comment: No mention of participant
blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 10% excluded due to regional
anaesthesia used - but after induction
Selective reporting (reporting bias) Low risk Comment: All relevant outcomes described
in Methods reported
Other bias Low risk Comment: None identified
Dedola 2008
Methods Study design: Randomized controlled trial
Study grouping: Parallel group
Participants Baseline Characteristics
Nitrous oxide-based - A
Number randomized: 24
Number analysed: 22
Age (mean): 43 (± 7)
% male: 9
Type of surgery: Elective abdominal surgery (laparotomic gynaecological surgery, laparo-
tomic correction of laparocele, pancreatoduodenectomy, hepatectomy)
Nitrous oxide-based - B
Number randomized: 26
Number analysed: 25
Age (mean): 40 (± 6)
% male: 8
Type of surgery: Elective abdominal surgery (laparotomic gynaecological surgery, laparo-
tomic correction of laparocele, pancreatoduodenectomy, hepatectomy)
Nitrous oxide-free - A
Number randomized: 26
Number analysed: 26
Age (mean): 39(± 8)
% male: 8
Type of surgery: Elective abdominal surgery (laparotomic gynaecological surgery, laparo-
tomic correction of laparocele, pancreatoduodenectomy, hepatectomy)
Nitrous oxide-free - B
Number randomized: 27
Number analysed: 25
Age (mean): 44(± 9)
% male: 24
Type of surgery: Elective abdominal surgery (laparotomic gynaecological surgery, laparo-
tomic correction of laparocele, pancreatoduodenectomy, hepatectomy)
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Dedola 2008 (Continued)
Included criteria: aged 20 - 50 years, ASA I, scheduled to undergo elective abdominal
surgery (laparotomic gynaecological surgery, laparotomic correction of laparocele, pan-
creatoduodenectomy, hepatectomy) requiring at least a 10-cm-long skin incision
Excluded criteria: Patients undergoing laparoscopic procedures, obese patients (BMI >
30 kg/m²), and patients with hypertension or a history of cardiac, pulmonary, or renal
diseases, drug or alcohol abuse, or current use of any medications that might affect the
cardiovascular system or block adrenergic responses to surgical incision
Interventions Intervention Characteristics
Nitrous oxide-based - A
Name: N3 Desflurane plus N O plus remifentanil 3 ng/ml
Induction: IV propofol (2 mg/kg) and TCI remifentanil 3 ng/ml for tracheal intubation,
which was facilitated by cisatracurium besilate (0.2 mg/kg)
Maintenance: desflurane plus 60%N O in oxygen TCI remifentanil 3 ng/ml. Up/down
procedure starting at desflurane 4%
Recovery: NR
Other drugs used: NR
Premedication: None
Duration of anaesthesia (min): NR
Nitrous oxide-based - B
Name: N1 Desflurane plus N O plus remifentanil 1 ng/ml
Induction: IV propofol (2 mg/kg) and TCI remifentanil 3 ng/ml for tracheal intubation,
which was facilitated by cisatracurium besilate (0.2 mg/kg)
Maintenance:Desflurane plus 60%N O in oxygen TCI remifentanil 1 ng/ml. Up/down
procedure starting at desflurane 4%
Recovery: NR
Other drugs used: NR
Premedication: None
Duration of anaesthesia (min): NR
Nitrous oxide-free - A
Name: A3 Desflurane plus remifentanil 3 ng/ml
Induction: IV propofol (2 mg/kg) and TCI remifentanil 3 ng/ml for tracheal intubation,
which was facilitated by cisatracurium besilate (0.2 mg/kg)
Maintenance: Desflurane plus 40% oxygen in air. TCI remifentanil 3 ng/ml. Up/down
procedure starting at desflurane 4%
Recovery: NR
Other drugs used: NR
Premedication: None
Duration of anaesthesia (min): NR
Nitrous oxide-free - B
Name: A1 Desflurane plus remifentanil 1 ng/ml
Induction: IV propofol (2 mg/kg) and TCI remifentanil 3 ng/ml for tracheal intubation,
which was facilitated by cisatracurium besilate (0.2 mg/kg)
Maintenance: Desflurane plus 40% oxygen in air. TCI remifentanil 1 ng/ml. Up/down
procedure starting at desflurane 5%
Recovery: NR
Other drugs used: NR
Premedication: None
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Dedola 2008 (Continued)
Duration of anaesthesia (min): NR
Monitoring: Desflurane monitored to designated MAC and remifentanil to designated
TCI conc. Adjustments made for next participant. Similar to previous investigations,
the MACBAR of desflurane was determined using an up/down sequential-allocation
technique. A participant’s response determined the concentration of desflurane given to
the following participants in each group. Arbitrarily started in the nitrous-free-remi-3 ng/
ml group with an end-tidal concentration of desflurane of 5% (0.83 MAC according to
the age of the studied population). Other groups started with an end-tidal concentration
of desflurane of 4% (0.6 MAC according to the age of the studied population). If the
response was positive (increase of either heart rate or MAP 15% above the mean of the
values measured during the 2 mins before skin incision), the end-tidal concentration
given to the next participant was increased by 0.5% (0.083 MAC). If the response was
negative, the end-tidal concentration of desflurane given to the next participant was
decreased by the same amount
Outcomes Accidental awareness
The day after surgery, all participants were interviewed to evaluate the presence of explicit
recall of any intraoperative event. At the postoperative visit 24 hrs after surgery, no
participant reported explicit recall of any intraoperative event
Identification Country: Italy
Setting: University hospital
Author’s name: A. Albertin
Institution: University of Milan and IRCCS Multimedica
Email: albertinsimone@yahoo.it
Address:A. Albertin,Department of Anesthesiology, IRCCSMultimedica, ViaMilanese
300, 20099 Sesto S. Giovanni, Milan, Ital
Aim of study To determine the effect of nitrous oxide on the desflurane requirement for blunting
sympathetic response following surgical incision (MACBAR) when desflurane was com-
bined with 2 different target-controlled concentrations of remifentanil (1 and 3 ng/ml)
Notes Very similar design to Albertin 2005
Lower proportion of men in nitrous oxide-free arm
Numbers in Table 1 do not add up to column total “A total of 98 patients completed
the study. Two patients in the A1 group, 1 patient in the N1 group and 2 patients in
the N3 group were excluded from the investigation because of a significant reduction in
MAP (<50 mmHg) before skin incision requiring administration of vasoconstrictors”
Sponsorship source: This study was supported by the Vita-Salute University of Milan
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Using a computer-generated se-
quence of numbers, patients were ran-
domly allocated”
Allocation concealment (selection bias) Unclear risk Comment: No details given
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Dedola 2008 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “The anesthesiologist recording
cardiovascular parameters, BIS values and
determining the positive - negative re-
sponse to surgical incision was blinded to
patient grouping”
Quote: “double-blind study”
Comment:Does not state who is blinded as
well as this anaesthetist. Anaesthetist deliv-
ering anaesthetic presumably not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Comment: No details about participants
but study described as double-blind. Does
not specify who asked about recall and
whether they were blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 5% lost, due to need for vasoac-
tive response
Selective reporting (reporting bias) Low risk Comment: All relevant outcomes described
in Methods reported
Other bias Low risk Comment: None identified
ENIGMA
Methods Study design: Randomized controlled trial
Study grouping: Parallel group
Participants Baseline Characteristics
19 participating centres of the ENIGMA trial group recruited participants between April
2003 and November 2004
Nitrous oxide-free - A
Number randomized: 1020
Number analysed: 997
Age (mean): 55.8 (± 17)
% male: 54
Type of surgery: Various - No cardiac/obstetric
Other information: ASA III 23%, IV 1.0%
Nitrous oxide-based - A
Number randomized: 1030
Number analysed: 1015
Age (mean): 54.6 (± 16)
% male: 51
Type of surgery: Various - No cardiac/obstetric
Other information: ASA III 24%, IV 1.1%
Included criteria: aged 18 yrs or older, scheduled to undergo general anaesthesia for
surgery that included a skin incision and that was anticipated to exceed 2 hrs, and were
expected to be in the hospital for at least 3 days after surgery
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ENIGMA (Continued)
Excluded criteria: Patients undergoing cardiac surgery, or thoracic surgery requiring
one-lung ventilation if the anaesthesiologist considered thatN Owas contraindicated (e.
g. a history of postoperative emesis or if the anaesthesiologist wanted to use supplemental
oxygen for colorectal surgery)
Interventions Intervention Characteristics
Nitrous oxide-free - A
Induction: Standard anaesthetic care and monitoring. Choice of anaesthetic drugs and
IV fluids at the discretion of the attending anaesthesiologist. Anaesthetic depth was ad-
justed according to clinical judgement and, if available, Bispectral Index monitoring.
Combined regional and general anaesthetic techniques could be included. Anaesthesiol-
ogists were advised to avoid intraoperative hypothermia (35.5°C). Inspired oxygen con-
centration could be increased to 100% in both groups at the conclusion of anaesthetic
administration. All other perioperative clinical care was conducted according to local
practice
Maintenance: 80% oxygen with 20% nitrogen recommended (but range of FiO 25 -
100% accepted according to clinical indication or anaesthetist preference
Recovery: NR
Other drugs used: NR
Premedication: NR
Duration of surgery: mean hrs 3.3 (± 2.0)
Nitrous oxide-based - A
Induction: Standard anaesthetic care and monitoring. Choice of anaesthetic drugs and
IV fluids at the discretion of the attending anaesthesiologist. Anaesthetic depth was ad-
justed according to clinical judgement and, if available, Bispectral Index monitoring.
Combined regional and general anaesthetic techniques could be included. Anaesthesiol-
ogists were advised to avoid intraoperative hypothermia (35.5°C). Inspired oxygen con-
centration could be increased to 100% in both groups at the conclusion of anaesthetic
administration. All other perioperative clinical care was conducted according to local
practice
Maintenance: 70% N O with 30% oxygen, after induction of anaesthesia, and until
completion of surgery. If haemoglobin oxygen saturation was inadequate, any airway
and ventilatory manoeuvres deemed necessary, including an increase in inspired oxygen
concentration, could be used
Recovery: NR
Other drugs used: NR
Premedication: NR
Duration of surgery: mean hr 3.3 (± 2.0)
Monitoring: Anaesthetic depth was adjusted according to clinical judgement and, if
available, Bispectral Index monitoring. Combined regional and general anaesthetic tech-
niques could be included. Bispectral monitoring used In nitrous oxide-free - A = 26%,
nitrous oxide-based - A = 16%
Outcomes Accidental awareness
Awareness: Postoperative recollection of intraoperative events, identified using a struc-
tured questionnaire, at 24 hrs and 30 days after surgery. Used Brice 1970 protocol
Identification Country:Multicentre international study. 19 trial centres
Setting: Australia, New Zealand, Hong Kong, Singapore, Saudi, UK
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Authors name: Paul S Myles
Institution: Alfred Hospital, Melbourne
Email: p.myles@alfred.org.au
Address:Department of Anaesthesia and PerioperativeMedicine, AlfredHospital, Com-
mercial Road, Melbourne, Victoria, 3004, Australia
Aim of study To evaluate whether avoidance of nitrous oxide in the gas mixture for anaesthesia, an
intervention that avoids potential nitrous oxide toxicity and in addition allows an increase
in the inspired oxygen fraction, could decrease the duration of hospital stay after surgery
and reduce postoperative complications, comparedwith a nitrous oxide-based anaesthetic
regimen, in adults presenting for major surgery
Notes Different FiO in each gp (nitrous-free 80% O , nitrous gp 30% O )
This study differs from others because the type of anaesthesia used was determined by the
anaesthetist Details given in Table 2. Differences include: (N O-free,N O respectively)
Bispectral Index monitoring, n (%) 259 (26) vs 160 (16), P = 0.001
Propofol maintenance anaesthesia, n (%) 191 (19) vs 132 (13), P = 0.001
End-tidal volatile concentration, median (IQR) MAC equivalents, 0.87 (0.61 - 1.06) vs
0.67 (0.52 - 0.83), P = 0.001
Sponsorship source: Supported by grants from the Australian National Health and
Medical Research Council, Australian and NewZealand College of Anaesthetists and the
Health and Health Services Research Fund (project 02030051), Hong Kong, People’s
Republic of China and a direct grant for research from the Chinese University of Hong
Kong (project #2041315)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “using a computer generated code,
accessed via an automated telephone voice
recognition service”
Allocation concealment (selection bias) Low risk Quote: “using a computer generated code,
accessed via an automated telephone voice
recognition service”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “Attending anesthesiologists were
required to have knowledge of group iden-
tity for the safe administration of anaesthe-
sia, but group identity was concealed from
the surgeon using drapes or cardboard to
screen the anaesthesia machine. At the end
of the procedure, the intra-operative case
report form and documentation of group
identity were faxed to the data manage-
ment center and then placed in an opaque
envelope by the anaesthesiologist. The en-
velope was then sealed to ensure blinding
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of research staff conducting the postopera-
tive follow-ups. The trial data management
center checked each completed record for
missing or illogical items within 24 - 48 h,
with corrections verified via e-mail contact
to the site coordinator and local study in-
vestigator. The anaesthesia record was not
concealed or removed from the patient’s
medical record, because it is our experi-
ence that the anaesthetic record is not pe-
rused by surgical staff. The patient and sur-
gical staff were not informed of the patient’s
group identity. All research staff, includ-
ing those responsible for postoperative data
collection and outcome assessment, were
precluded by protocol from accessing the
anaesthetic record and so were blinded to
group identity
Patients and observers were blind to group
identity”
Comment: Anaesthetist not blinded and
able to chose different anaesthetic agents
andmonitoring. Large difference in%with
bispectral monitoring in 2 groups
Participants blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “Attending anaesthesiologists were
required to have knowledge of group iden-
tity for the safe administration of anesthe-
sia, but group identity was concealed from
the surgeon using drapes or cardboard to
screen the anesthesia machine. At the end
of the procedure, the intra- operative case
report form and documentation of group
identity were faxed to the data manage-
ment center and then placed in an opaque
envelope by the anaesthesiologist. The en-
velope was then sealed to ensure blinding
of research staff conducting the postopera-
tive follow-ups. The trial data management
center checked each completed record for
missing or illogical items within 24 - 48 h,
with corrections verified via e-mail contact
to the site coordinator and local study in-
vestigator. The anesthesia record was not
concealed or removed from the patient’s
medical record, because it is our experi-
ence that the anaesthetic record is not pe-
rused by surgical staff. The patient and sur-
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ENIGMA (Continued)
gical staff were not informed of the patient’s
group identity. All research staff, includ-
ing those responsible for postoperative data
collection and out- come assessment, were
precluded by protocol from accessing the
anaesthetic record and so were blinded to
group identity”
Comment: Participants and research staff
assessing outcomes were blinded to alloca-
tion
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “intention-to- treat population for
all primary and secondary analyses”
Comment: 2.3% loss vs 1.5% loss. Both
low
Selective reporting (reporting bias) Low risk Comment: All relevant outcomes specified
in Methods were reported
Other bias Low risk Comment: None identified
Girardi 1994
Methods Study design: Randomized controlled trial
Study grouping: Parallel group
Participants Baseline Characteristics
Nitrous oxide-free - A
Number randomized: 26
Number analysed: 26
Age (mean): 40 - 54
% male: 0
Type of surgery: Varicose veins
Nitrous oxide-based - A
Number randomized: 25
Number analysed: 25
Age (mean): 40 - 54
% male: 0
Type of surgery: Varicose veins
Included criteria: Women, ASA class I, surgery for venous disease of the lower limbs
Excluded criteria: Previous neurological or psychiatric disease
Interventions Intervention Characteristics
Nitrous oxide-free - A
Name: Thiopental + air + isoflurane 5% - 2%
Induction: Thipoental 3.5 mg/kg. Until intubation, isoflurane 5% in air and oxygen
(40% O )
Maintenance: Isoflurane 2% in air (40% O )
Recovery: NR
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Other drugs used: Atracurium 0.6 mgkg-1
Premedication: 45 mins before induction: Atropine 0.007 mg/kg, pethidine 1 mg/kg
Duration of anaesthesia (min): - 86.2 (± 12.3)
Nitrous oxide-based - A
Name: Thiopental + N O 60% + Isoflurane 3% - 1.2%
Induction: Thipoental 3.5 mg/kg. Until intubation isoflurane 3% in 60% N O and
40% oxygen
Maintenance: Isoflurane 1.2% in 60% N O and 40% oxygen
Recovery: NR
Other drugs used: Atracurium 0.6 mg/kg
Premedication: 45 mins before induction: Atropine 0.007 mg/kg, pethidine 1 mg/kg
Duration of anaesthesia (min): 89.5 (± 10.3)
Monitoring: Depth of anaesthesia assessed using Evans score for clinical signs depth,
plus ECG monitoring (Compressed Spectral Array. Brain Surveyor)
Outcomes Accidental awareness
Collected 60 mins and 24 hrs after surgery, through a structured questionnaire. Partici-
pants were asked:
The last thing they remembered before going to sleep
The first thing they remembered when they woke up
Does the patient believe they remembered anything about the operation, if yes, can it
be related to actual events?
Did the patient experience pain during the operation?
Did the patient dream during the operation? If yes, what? Emotional tone of the dream?
Final judgement on the experience
Identification Country: Italy
Setting: University clinic
Authors name: G Della Rocca
Institution: Instituto do Anestesiologia e Riaanimazione, Universita Degli di Firenze
Email: Not reported
Address: Istituto do anestesiologia e Rianimazione, Policlinico di Careggi, Viale Mor-
gangni, 85 50123 Firenze
Aim of study To control the depth, the quality of recovery of total inhalation isoflurane anaesthesia
with or without nitrous oxide
Notes Sponsorship source: No details given
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information
Allocation concealment (selection bias) Unclear risk No information
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk No losses to follow-up reported
Selective reporting (reporting bias) Low risk All relevant outcomes specified inMethods
reported
Other bias Low risk None identified
Handa 2010
Methods Study design: Randomized control trial
Study grouping: Parallel group
Participants Baseline Characteristics
118 participants (men n = 38, women n = 80)
Nitrous oxide-free - A
Number randomized: 58
Number analysed: 58
Age (mean): NR
% male: 18/58 = 31.0%*
Type of surgery: Saggital split ramus osteotomy
Nitrous oxide-based - A
Number randomized: 60
Number analysed: 60
Age (mean): NR
% male: 20/60 = 33.3%*
Type of surgery: Saggital split ramus osteotomy
Included criteria: Patients undergoing saggital split ramus osteotomy between August
2008 - April 2009
Excluded criteria: History of alcoholism, substance misuse, psychiatric disorders, dis-
orders which may affect metabolism of anaesthetic drugs
Interventions Intervention Characteristics
Nitrous oxide-free - A
Name: Air - Oxygen - Propofol group
Induction: Fentanyl 2 mcg/kg, vecuronium/rocuronium, TCI propofol 3.5 mcg/ml
plasma target concentration
Maintenance: TCI propofol 3.0 - 4.0 mcg/ml plasma target concentration. Additional
fentanyl bolus as required based on haemodynamics, surgical stimulation, FiO 0.33,
Local anaesthetic infiltration by surgeons (lignocaine/adrenaline), Atropine/neostigmine
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neuro-muscular blockade reversal
Recovery: PCA fentanyl with droperidol
Other drugs used: Muscle relaxant = vecuronium/rocuronium (dose unspecified) for all
participants
Premedication: None
Duration of anaesthesia (mins) = NR
Nitrous oxide-based - A
Name: Nitrous oxide-Oxygen-Propofol group
Induction: Fentanyl 2 mcg/kg, vecuronium/rocuronium, TCI propofol 3.5 mcg/ml
plasma target concentration
Maintenance: TCI propofol 3.0 - 4.0 mcg/ml plasma target concentration, additional
fentanyl bolus as required based on haemodynamics, surgical stimulation, FiO 0.33,
local anaesthetic infiltration by surgeons (lignocaine/adrenaline), atropine/neostigmine
neuro-muscular blockade reversal
Recovery: PCA fentanyl with droperidol
Other drugs used: Muscle relaxant = vecuronium/rocuronium (dose unspecified) for all
participants
Premedication: None
Duration of anaesthesia (mins) = NR
Monitoring: Haemodynamics
Outcomes Accidental awareness
Details: Participants interviewed once able to obey commands and answer questions
verbally in recovery room with regards to presence of dreams during anaesthesia. Fur-
thermore, participants requested to fill in a paper questionnaire 24 hrs post-op
Questionnaire asked ‘Do you have memories of the surgery’ and ‘Did you dream some-
thing’ If answered ‘yes’ to awareness participant asked to state whether they:
1. Heard something
2. Felt pain
3. Felt vibration
4. Felt paralysed
5. Other
No participants reported awareness
Identification Country: Japan
Setting: Operating theatre in single centre
Authors name: Handa
Institution: Tokyo Dental College
Email: Not stated
Address: Not stated
Aim of study We investigated the frequency and the content of dreams during propofol anaesthesia in
patients undergoing mandibular sagittal split ramus osteotomy (SSRO)
Notes *Error in table 2 stating number of men/women in this subdivision - i.e. Table 2 states
40 men to 18 women in this branch of study group which contradicts the total number
of men/women recruited and also what is stated in the main body of text
Sponsorship source: NR
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: No method stated for random-
ization
Allocation concealment (selection bias) Unclear risk Comment: No information
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: No information
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Comment: No information
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: No attrition
Selective reporting (reporting bias) Low risk Comment: Main aim of study to ascer-
tain incidence and nature of dreaming dur-
ing anaesthesia, however awareness stated
as the other measured outcome in study
methodology
Other bias Low risk Comment: None identified
Handa Tsutsui 2007
Methods Study design: Randomized controlled trial
Study grouping: Parallel group
Participants Baseline Characteristics
Nitrous oxide-free - A
Number randomized: 23
Number analysed: 23
Age (mean): 35 (± 3.3)
% male: 0
Type of surgery: Transvaginal US guided oocyte retrieval for in-vitro fertilization
Nitrous oxide-based - A
Number randomized: 24
Number analysed: 24
Age (mean): 36 (± 7.8)
% male: 0
Type of surgery: Transvaginal US guided oocyte retrieval for in-vitro fertilization
Included criteria: Women ASA class I - II, unpremedicated and undergoing scheduled
transvaginal ultrasound-guided oocyte retrieval were recruited
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Excluded criteria: NR
Interventions Intervention Characteristics
Nitrous oxide-free - A
Name: Propofol + air
Induction: Propofol was started at target concentration using a Diprifusor™ anaesthesia
pump
Maintenance: Oxygen-enriched air (FiO 0.5). Participants experiencing movement im-
mediately had their propofol plasma-site concentration increased to 6 - 10 mcg/ml. Tar-
get concentration of propofol was started at 4 mcg/ml for the first participant. Subse-
quent participants received target concentration 0.5 mcg/ml higher or lower using up/
down sequential allocation. If the response of the previous woman was movement, the
target concentration for the next participant was increased by 0.5mcg/ml. If the response
was no movement, the next target concentration was reduced
Recovery: Recovery time (mins) 11 (± 6.2)
Other drugs used: NR
Premedication: To reduce vascular pain, 2% lidocaine 1 mg/kg was administered IV
before propofol induction
Duration of anaesthesia (mins): NR
Nitrous oxide-based - A
Name: Propofol + nitrous oxide
Induction: Propofol was started at target concentration using a Diprifusor™ anaesthesia
pump
Maintenance: After induction of anaesthesia, mask ventilation was maintained with 50%
N O and 50% oxygen. Participants experiencing movement immediately had their
propofol plasma-site concentration increased to 6 - 10 mcg/ml.Target concentration
of propofol was started at 4 mcg/ml for the first participant. Subsequent participants
received target concentration 0.5 mcg/ml higher or lower using up/down sequential
allocation. If the response of the previouswomanwasmovement, the target concentration
for the next participant was increased by 0.5 mcg/ml. If the response was no movement,
the next target concentration was reduced
Recovery: NR. Recovery time (mins)12 (± 4.7)
Other drugs used: NR
Premedication: To reduce vascular pain, 2% lidocaine 1mg/kg was administered iv before
propofol induction
Duration of anaesthesia (min): NR
Monitoring: as described above, up/down dosing method used. Depth of anaesthesia in
both groups should be equivalent
Outcomes Accidental awareness
“All women were interviewed about memory recall and post-procedure pain in the
recovery room.” “Direct questioning in the recovery room yielded no complaint of recall
of the procedure or anaesthesia”
Identification Country: Japan
Setting: NR
Authors name: F. Handa-Tsutsui
Institution: Department of Anesthesiology, Saitama Medical Center, Kamoda
Email: PXN01110@nifty.com
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Handa Tsutsui 2007 (Continued)
Address:Dept. of Cardiac Surgery, Saitama Medical School, Moroyama, Saitama, 350-
0495 Japan
Aim of study Determine the target concentration of propofol required to prevent movement in 50%
(Cp50) and 95% (Cp95) of women during oocyte retrieval, and investigated whether
supplemental N O modified the Cp50 and Cp95
Notes Sponsorship source: Saitama MedicalCenter. Neither author has corporate support or
any relationship with commercial companies
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomly assigned
into two groups using random table:”
Comment: No further details
Allocation concealment (selection bias) Unclear risk Quote: “Patients were randomly assigned
into two groups using random table:”
Comment: No further details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: Presume anaesthetists not
blinded. No mention of participant blind-
ing
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Comment: Not clear if same investigators
asked about recall. No mention of partici-
pant blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: No attrition
Selective reporting (reporting bias) Low risk Comment: All relevant outcomes described
in Methods reported
Other bias Low risk Comment: None identified
Heath 1996
Methods Study design: Randomized controlled trial
Study grouping: Parallel group
Participants Baseline Characteristics
Nitrous oxide-free - A
Number randomized: NR
Number analysed: NR
Age (mean): NR
49Nitrous oxide-based versus nitrous oxide-free general anaesthesia and accidental awareness during general anaesthesia in surgical
patients (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Heath 1996 (Continued)
% male: 0
Type of surgery: Routine gynaecological surgery
Nitrous oxide-based - A
Number randomized: NR
Number analysed: NR
Age (mean): NR
% male: 0
Type of surgery: Routine gynaecological surgery
Included criteria: Women, ASA I & II, undergoing routine gynaecological surgery
Excluded criteria: NR
Interventions Intervention Characteristics
Nitrous oxide-free - A
Name: Propofol + air
Induction: Propofol 10 mg/ml + alfentanil 30 mcg/ml in same 50ml syringe. Initial bolus
of 0.2 ml/kg at 800 ml/hrIf required for intubation or during surgery - vecuronium 0.1
mg/kg initial bolus
Maintenance: Maintained using same mixture at initial rate of 1 ml/kg/hr. Ventilated
with oxygen and air FiO 30%
.
Experienced anaesthetists adjusted as required to main-
tain depth. Volume of propofol/alfentanil = 49.6 ml. Further boluses of 0.025 mg/kg
vecuronium as required
Recovery: NR
Other drugs used: Intraoperative analgesia by lumbar or caudal epidural injection of 20ml
0.25% bupivacaine. When epidural analgesia was not indicated participants received IV
morphine during the operation. All participants received diclofenac 100 mg per rectum,
unless contraindicated, after induction of an anaesthesia
Premedication: Temazepam 20 mg orally
Duration of anaesthesia (mins): NR
Nitrous oxide-based - A
Name: Propofol + N O
Induction: Propofol 10 mg/ml + alfentanil 30 mcg/ml in same 50ml syringe. Initial bolus
of 0.2 ml/kg at 800 ml/hrIf required for intubation or during surgery - vecuronium 0.1
mg/kg initial bolus
Maintenance:Maintained using samemixture at initial rate of 1ml/kg/hr. Ventilatedwith
oxygen and nitrous oxide, FiO 67%. Experienced anaesthetists adjusted as required to
maintain depth.Volume of propofol/alfentanil = 39.3 ml. Further boluses of 0.025 mg/
kg vecuronium as required
Recovery: NR
Other drugs used: Intraoperative analgesia by lumbar or caudal epidural injection of 20ml
0.25% bupivacaine. When epidural analgesia was not indicated participants received IV
morphine during the operation. All participants received diclofenac 100 mg per rectum,
unless contraindicated, after induction of an anaesthesia
Premedication: Temazepam 20 mg orally
Duration of anaesthesia (mins): NR
Monitoring: Experienced anaesthetists adjusted as required to maintain depth. No de-
tails given of what was monitored
Intraoperative stimulation: no additional measures
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Outcomes Accidental awareness
Participants asked about any evidence that awareness occurred during anaesthesia at 4
hrs and 24 hrs post-op. No reports of awareness
Identification Country: UK
Setting: Military hospital
Authors name: K.J. Heath
Institution: Cambridge Military Hospital
Email: NR
Address: Anaesthetic Department, Addenbrookes Hospital, Cambridge, UK
Aim of study To calculate the cost of an IV anaesthetic technique using a mixture of propofol and
alfentanil when nitrous oxide and oxygen were used instead of oxygen-enriched air and
to assess the postoperative complications of the 2 different techniques
Notes Numbers in individual groups not given (total = 101)
Sponsorship source: NR
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “patients allocated randomly into
two groups”
No further details
Allocation concealment (selection bias) Unclear risk Comment: No details given
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: Presume anaesthetist not
blinded and the depth of anaesthetic ad-
justed by anaesthetist. No mention of par-
ticipant blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Comment: Participants were visited by an
anaesthetist who was unaware of the anaes-
thetic technique used. Not clear whether
participants blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: No details given and no num-
bers in each group
Selective reporting (reporting bias) Low risk Comment: All relevant outcomes described
in Methods were reported
Other bias Low risk Comment: None identified
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Lindekaer 1995
Methods Study design: Randomized controlled trial
Study grouping: Parallel group
Participants Baseline Characteristics
Nitrous oxide-free - A
Number randomized: 21
Number analysed: 21
Age (mean): 44 (± 12.2)
% male: 90.5
Type of surgery: Inguinal herniotomy
Nitrous oxide-based - A
Number randomized: 21
Number analysed: 21
Age (mean): 47 (± 10.6)
% male: 95.2
Type of surgery: Inguinal herniotomy
Included criteria: aged 18 - 60 years, ASA 1 or 2, scheduled for day-case inguinal
herniotomy
Excluded criteria: NR
Interventions Intervention Characteristics
Nitrous oxide-free - A
Name: Propofol + air
Induction: Alfentanil 15 mcg/kg and propofol 2 mg/kg IV followed by alfentanil 45
mcg/kg/hr and propofol 10mg/kg/hr. Tracheal intubation was facilitated by vecuronium
85 mcg/kg
Maintenance: Separate infusions of alfentanil 45 mcg/kg/hr and propofol 10 mg/kg/hr
participant’s lungs were manually ventilated with air/O . FiO 30%. Propofol infusion
was continued for 5 mins then reduced to a minimum rate judged clinically on the signs
of ‘light’ anaesthesia: movement, lacrimation, sweating, arrhythmia,tachycardia, increas-
ing arterial blood pressure compared to baseline measurements. If necessary, boluses of
propofol (20 mg) could be administered
Recovery: Alfentanil and propofol infusions were stopped at fascia and skin closure re-
spectively. After skin closure the participant’s lungs were ventilated with oxygen only and
muscle relaxation was reversed with atropine and neostigmine
Other drugs used:
Premedication: Diazepam 0.15 mg/kg by mouth and naproxen 1 g per rectum 30 mins
before operation
Duration of infusion: Min 68 (± 19.1), mean maintenance propofol 0.088 mg/kg/min
Nitrous oxide-based - A
Name: Propofol + N O
Induction: Alfentanil 15 mcg/kg and propofol 2 mg/kg/hr IV followed by alfentanil 45
mcg/kg/hr and propofol 10mg/kg/hr. Tracheal intubation was facilitated by vecuronium
85 mcg/kg
Maintenance: separate infusions of alfentanil 45 mcg/kg/hr and propofol 10 mg/kg/hr
participant’s lungs were manually ventilated with N O/O with a FiO of 0.30. Propo-
fol infusion was continued for 5 mins then reduced to a minimum rate judged clini-
cally on the signs of ‘light’ anaesthesia: movement, lacrimation, sweating, arrhythmia,
tachycardia, increasing arterial blood pressure compared to baseline measurements. If
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necessary, boluses of propofol (20 mg) could be administered
Recovery: The alfentanil and propofol infusions were stopped at fascia and skin closure
respectively. After skin closure the participant’s lungs were ventilated with oxygen only
and muscle relaxation was reversed with atropine and neostigmine
Other drugs used:
Premedication: Diazepam 0.15 mg/kg-1 by mouth and naproxen 1g per rectum 30 mins
before operation
Duration of infusion: Min 66 (± 19.3) mean maintenance propofol 0.084 mg/kg/min
Monitoring: The propofol infusion was continued for 5 mins at this rate; it was then
reduced to a minimum rate judged clinically on the signs of ‘light’ anaesthesia: move-
ment, lacrimation, sweating, arrhythmia, tachycardia, increasing arterial blood pressure
compared to baseline measurements. If necessary, boluses of propofol (20 mg) could be
administered and these were recorded
Outcomes Accidental awareness
“Before discharge from hospital the anaesthetist questioned the patients about possible
awareness during the operation or any dreams.”
“Two hours after propofol all the patients felt well; none had any unpleasant recollection
of events during anaesthesia but one patient reported pleasant dreams”
Identification Country: Denmark
Setting: University hospital
Authors name: AL Lindekaer
Institution: University of Copenhagen
Email: NR
Address: AL Lindekrer, Virumvej 104 B, 2830 Virum, Denmark
Aim of study To evaluate the influence of N O on the infusion rate of propofol, allowing anaesthetic
depth, as evaluated clinically, to determine the infusion rate
Notes Sponsorship source: “We thank AGA for their support of the study”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “by random allocation”
Comment: No further details
Allocation concealment (selection bias) Unclear risk Quote: “by random allocation”
Comment: No further details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “nurse, whowas not involved in ad-
justing the propofol infusion rate, adjusted
the flowmeters for both groups to give an
inspired oxygen fraction (FiO ) of 0.30.”
Quote: “double blind design”
Comment: States double-blind but does
not say who was blinded
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: “double blind design”
Quote: “anaesthetist questioned the pa-
tients about possible awareness during the
operation or any dreams”
Comment: Described as double-bind but
nodetails ofwhowas blinded. Anaesthetist,
who presumably was not blinded, asked
about awareness
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: No apparent attrition
Selective reporting (reporting bias) Low risk Comment: All relevant outcomes described
in Methods reported
Other bias Low risk Comment: None identified
Ngan Kee 2002
Methods Study design: Randomized controlled trial
Study grouping: Parallel group
Participants Baseline Characteristics
Nitrous oxide-free - A
Number randomized: 20
Number analysed: 20
Age (mean): 35 (range 27 - 43)
% male: 0
Type of surgery: Caesarean section
Nitrous oxide-based - A
Number randomized: 20
Number analysed: 20
Age (mean): 34 (range 26 - 41)
% male: 0
Type of surgery: Caesarean section
Nitrous oxide-based - B
Number randomized: 20
Number analysed: 20
Age (mean): 34 (range 27 - 41)
% male: 0
Type of surgery: Caesarean section
Included criteria: ASA I and II women with term singleton pregnancies having elective
Caesarean section under GA
Excluded criteria: Pre-existing or pregnancy-induced hypertension, cardiovascular or
cerebrovascular disease or known foetal abnormalities
Interventions Intervention Characteristics
Nitrous oxide-free - A
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Name: Sevoflurane
Induction: Pre-oxygenation rapid sequence induction using thiopental 4 mg/kg and suc-
cinylcholine 1.5 mg/kg atracurium as required for further muscle relaxation as indicated
by results of peripheral nerve stimulation
Maintenance: Lungs ventilated tomaintain end-tidal CO concentration of 4.3 kPa. FiO
1.0 with end-tidal sevoflurane 2.0%. Circle circuit with a fresh gas flow of 6 l/min was
used and for all participants sevoflurane vaporiser was originally set to 6% for the first
60 secs and then adjusted to the required end-tidal concentration
Recovery: Neostigmine and atropine
Other drugs used: Ranitidine 150 mg night before surgery 30 ml 0.3 M sodium citrate
on arrival at theatre
Premedication: NR
Duration of anaesthetic (mins): NR
Nitrous oxide-based - A
Name: Sevoflurane + Fi N O 0.5
Induction: Pre-oxygenation rapid sequence induction using thiopental 4 mg/kg and suc-
cinylcholine 1.5 mg/kg atracurium as required for further muscle relaxation as indicated
by results of peripheral nerve stimulation
Maintenance: Lungs ventilated to maintain end-tidal CO concentration of 4.3 kPa.
Inspired fractions chosen to give approximately equivalentMACvalues in all groups. FiO
0.5 + FiN O 0.5 with end-tidal sevoflurane 1.0%. Circle circuit with a fresh gas flow
of 6 l/min was used and for all participants sevoflurane vaporiser was originally set to
6% for the first 60 secs and then adjusted to the required end-tidal concentration
Recovery: Neostigmine and atropine
Other drugs used: Ranitidine 150 mg night before surgery 30 ml 0.3 M sodium citrate
on arrival at theatre
Premedication: NR
Duration of anaesthetic (mins): NR
Nitrous oxide-based - B
Name: Sevoflurane +Fi N O 0.7
Induction: Pre-oxygenation rapid sequence induction using thiopental 4 mg/kg and suc-
cinylcholine 1.5 mg/kg atracurium as required for further muscle relaxation as indicated
by results of peripheral nerve stimulation
Maintenance: Lungs ventilated tomaintain end-tidalCO conc of 4.3 kPa. FiO 0.3FiN
O 0.7 with end-tidal sevoflurane 0.6%. Circle circuit with a fresh gas flow of 6 l/min
was used and for all participants sevoflurane vaporiser was originally set to 6% for the
first 60 secs and then adjusted to the required end-tidal concentration
Recovery: Neostigmine and atropine
Other drugs used: Ranitidine 150 mg night before surgery 30 ml 0.3 M sodium citrate
on arrival at theatre
Premedication: NR
Duration of anaesthetic (mins): NR
Monitoring: Anaesthetics in different groups aimed to give same overall MAC. Anaes-
thetic concentration adjusted tomaintain allocated end-tidal concentration. Nomention
of adjusting anaesthetic concentration according to participant’s response or haemody-
namic variables
Outcomes Accidental awareness
“Each patients was visited by a research nurse on the first day after the operation who
asked if the patient was able to recall any intra-operative events or remembered any
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Ngan Kee 2002 (Continued)
dreams during the operation”
“No patient reported recall of intraoperative events”
Identification Country: Hong Kong
Setting: University Hospital
Authors name: WDNgan Kee
Institution: Prince of Wales Hospital, Shatin, Hong Kong
Email: NR
Address: NR
Aim of study To compare the effect of FiO of 0.3, 0.5 and 1.0 on umbilical cord blood oxygen
content in participants having elective Caesarean section under anaesthesia
Notes Obstetric patients. Anaesthetics in different groups aimed to give same overall MAC
Sponsorship source: Direct Grant for research from the Chinese University of Hong
Kong
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were then randomly al-
located to one of three groups by drawing
of sequentially numbered sealed envelopes
that each contained a computer-generated
randomization code”
Allocation concealment (selection bias) Low risk Quote: “randomly allocated to one of three
groups by drawing of sequentially num-
bered sealed envelopes that each contained
a computer-generated randomization code.
”
Comment: Probably was concealed alloca-
tion
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “Patients were not informed of the
group allocation. One anaesthetist was re-
sponsible for controlling the delivery of the
anaesthetic. Separate investigators were re-
sponsible for the blood sampling and anal-
ysis. To mask these investigators and the
surgeon to the treatment, the anaesthesia
machine was turned away so the monitors
were not visible to them”
Comment: Anaesthetists not blinded but
anaesthetic inspired concentrations set
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Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “Each patient was visited on the
first day after operation by a research nurse,
who asked the patient if she was able to
recall any intraoperative events”
Comment: Not clear whether these re-
search nurses were blinded. Participants
were blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: No reported attrition
Selective reporting (reporting bias) Low risk Comment: All relevant outcomes described
in Methods were reported
Other bias Low risk Comment: None identified
Singh 2011
Methods Study design: Randomized controlled trial
Study grouping: Parallel group
Participants Baseline Characteristics
Nitrous oxide-free - A
Number randomized: 60
Number analysed: 46
Age (mean): 36.6 (± 9.6)
% male: 58.7
Type of surgery: elective supratentorial tumour surgery
Other information: mean tumour vol cm³ 164.2 (± 280.7)
Nitrous oxide-based - A
Number randomized: 56
Number analysed: 41
Age (mean): 36.1 (± 11.6)
% male: 65.9
Type of surgery: elective supratentorial tumour surgery
Other information: mean tumour vol cm³ 159.7 (± 278.3)
Included criteria: patients between 18 and 60 years of age, either gender, ASA I and
II, scheduled for elective supratentorial tumour surgery, with anticipated duration of
anaesthesia more than 4 hours
Excluded criteria: history of smoking, patients with history of megaloblastic anaemia,
those requiring postoperative mechanical ventilation, patients receiving vitamin B12/
folic acid supplementation, history of exposure to general anaesthesia in the last month,
history of motion sickness/postoperative emesis, evidence of pneumothorax/pneumo-
cephalus, and bleeding disorders
Interventions Intervention Characteristics
Nitrous oxide-free - A
Name: Isoflurane + air +O
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Induction: fentanyl 2 mcg/kg and thiopentone 4 to 6 mg/kg and tracheal intubation
facilitated with rocuronium 1 mg/kg. Additional dose of thiopentone 1 - 2 mg/kg was
given before laryngoscopy and intubation to prevent the pressor response
Maintenance: Isoflurane (end-tidal concentration: 1.2%). Oxygen and air (FiO ) Inter-
mittent doses of fentanyl (1mcg/kg) and vecuronium (0.01 mg/kg) repeated as required.
Use of other drugs and IV fluids was at the discretion of the attending anaesthesiologist.
Anaesthetic depth was adjusted according to clinical judgement
Recovery: At the end of the surgery, anaesthetic agent (isoflurane) was discontinued at
the beginning of skin closure and the medical air switched off at the time of dressing of
the surgical site. Residual neuromuscular block was reversed with neostigmine 0.05 mg/
kg and glycopyrrolate 0.01 mg/kg, and trachea extubated after neurologic assessment
Other drugs used: Mannitol (1 gm/kg) was given to all participants over a period of 20
to 30 mins, starting at the time of skin incision
Premedication: Glycopyrrolate 0.2mg intramuscularly was given 1 hour before the sched-
uled surgery
Duration of anaesthesia (mins): NR
Nitrous oxide-based - A
Name: Isoflurane + N O + O
Induction: Fentanyl 2 mcg/kg and thiopentone 4 to 6 mg/kg and tracheal intubation
facilitated with rocuronium 1 mg/kg. Additional dose of thiopentone 1 to 2 mg/kg was
given before laryngoscopy and intubation to prevent the pressor response
Maintenance: Isoflurane (end-tidal concentration: 0.7%) oxygen and N O (FiO ). In-
termittent doses of fentanyl (1 mcg/kg) and vecuronium (0.01 mg/kg) repeated as re-
quired. Use of other drugs and IV fluids was at the discretion of the attending anaesthe-
siologist. Anaesthetic depth was adjusted according to clinical judgement
Recovery: At the end of the surgery, anaesthetic agent (isoflurane) was discontinued at
the beginning of skin closure and the N O switched off at the time of dressing of the
surgical site. Residual neuromuscular block was reversed with neostigmine 0.05 mg/kg
and glycopyrrolate 0.01 mg/kg, and trachea extubated after neurologic assessment
Other drugs used: Mannitol (1 gm/kg) was given to all participants over a period of 20
to 30 mins, starting at the time of skin incision
Premedication: Glycopyrrolate 0.2mg intramuscularly was given 1 hour before the sched-
uled surgery
Duration of anaesthesia (min): NR
Monitoring: Anaesthetic gases kept at set flow rate. Intermittent doses of fentanyl (1
mcg/kg) and vecuronium (0.01 mg/ kg) repeated as required. Anaesthetic depth was
adjusted according to clinical judgement
Outcomes Accidental awareness
Awareness: Postoperative recollection of intraoperative events identified using a struc-
tured questionnaire at 24 hrs after surgery. a) What was the last thing you remembered
happening before you went to sleep? b) What is the last thing you remembered hap-
pening on awakening? c) Did you dream or have any other experience whilst you were
asleep? d) What was the worst thing about your operation? e) What was the next worst?
No participant in either group reported awareness of intraoperative events
Identification Country: India
Setting: University hospital
Authors name: Dr. Hemanshu Prabhakar
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Institution: All India Institute of Medical Sciences
Email: prabhakarhemanshu@rediffmail.com
Address:Department ofNeuroanesthesiology,NeurosciencesCenter, 7th Floor, All India
Institute of Medical Sciences,New Delhi - 110 029, India
Aim of study To evaluate if avoidance of nitrous oxide could decrease the duration of Intensive Care
Unit (ICU) and hospital stay after elective surgery for supratentorial tumours
Notes 29 participants could not be tracheally extubated at the end of surgery (15 in nitrous
oxide-based group and 14 in nitrous oxide-free group)
Sponsorship source: Source of support - nil; Conflict of interest - none declared
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Patients were randomly divided
into two groups by a computer-generated
randomization chart”
Allocation concealment (selection bias) Unclear risk Quote: “Patients were randomly divided
into two groups by a computer-generated
randomization chart”
Comment: No details of allocation con-
cealment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “Attending anesthesiologist was
aware of the group identity (for safe ad-
ministration of anesthesia), but it was con-
cealed from the surgeons (using drapes to
cover the anesthesia machine)”
Quote: “double blinded”
Comment: Described as double-blind. No
explicit mention of participant blinding
but unlikely to know. Anaesthetist was un-
blinded and depth of anaesthesia at discre-
tion
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “double blinded”
Comment: Assessors blinded
Quote: “Staff conducting the postoperative
follow-ups (i.e., those responsible for post-
operative data collection and outcome as-
sessment) was blinded to the group iden-
tity”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Of the 116 patients, 29 patients
could not be tracheally extubated at the end
of surgery (15 patients in group I and 14 in
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group II), and so the data of these patients
were excluded from final analysis”
Comment: 23.3% in N O-free group and
26.8% in N O-based group excluded
Selective reporting (reporting bias) Low risk Comment: All relevant outcomes described
in Methods were reported
Other bias Low risk Comment: None identified
Sukhani 1994
Methods Study design: Randomized controlled trial
Study grouping: Parallel group
Participants Baseline Characteristics
Nitrous oxide-free - A
Number randomized: 36
Number analysed: 36
Age (mean): 30.1 (± 4.9)
% male: 0
Type of surgery: gynaecological laparoscopy
Nitrous oxide-based - A
Number randomized: 34
Number analysed: 34
Age (mean): 34.6 (± 5.6)
% male: 0
Type of surgery: gynaecological laparoscopy
Included criteria:Adult non-pregnant women aged19 - 40 yrs scheduled for ambulatory
gynaecological laparoscopy
Excluded criteria: Weight > 150% of ideal body weight or had predisposing factors for
delayed gastric emptying such as diabetes, chronic cholecystectitis, scleroderma, neu-
ropathies, and neuromuscular disorders. Women who demonstrated significant anxiety
and who, in the anaesthesiologist’s judgement required pre-operative anxiolytic therapy
were also excluded
Interventions Intervention Characteristics
Nitrous oxide-free - A
Name: Propofol + air +O
Induction: Lidocaine /kg given IV propofol infusion started 200 mcg/kg/min Induction
dose of propofol IV 2 - 2.5 mg/kg over 1 min until loss of eyelash reflex. Tracheal
intubation facilitated with atracurum 0.5 mg/kg. Ventilation controlled and minute
ventilation adjusted to maintain end-tidal CO at 35 (± 5) mm-Hg
Maintenance: Infusion rate of propofol was adjusted to maintain adequate depth of
anaesthesia as indicated by clinical signs and haemodynamic changes. Ventilated with
mixture of air and O - FiO 30%
Recovery: 10 mins before expected conclusion of surgery propofol infusion discontinued
and 10 mg boluses given as clinically indicated. Gas mixture switched to 100% oxygen
when skin suturing complete. Muscle relaxant reversed with neostigmine 50 mcg/kg and
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glycopyrolate 10 mcg/kg
Other drugs used: Additional doses of atracurium were used if clinically indicated
Premedication: None
Duration of surgery (mins): 51.0 (± 17.1)
Duration of Anaesthesia (mins): 82.7 (± 24.5)
Nitrous oxide-based - A
Name: Propofol +N O+O
Induction: Lidocaine 1mg/kg given IV propofol infusion started 200 mcg/kg/min In-
duction dose of propofol IV 2 - 2.5mg/kg over 1 min until loss of eyelash reflex. Tracheal
intubation facilitated with atracurum 0.5mg/kg. Ventilation controlled and minute ven-
tilation adjusted to maintain end-tidal CO at 35 (±5) mm-Hg
Maintenance: Infusion rate of propofol was adjusted to maintain adequate depth of
anaesthesia as indicated by clinical signs and haemodynamic changes.Ventilated with
mixture of N O and O - FiO 30%
Recovery: 10 mins before expected conclusion of surgery propofol infusion discontinued
and 10 mg boluses given as clinically indicated. Gas mixture switched to 100% oxygen
when skin suturing complete. Muscle relaxant reversed with neostigmine 50 mcg/kg and
glycopyrolate 10 mcg/kg
Other drugs used: Additional doses of atracurium were used if clinically indicated
Premedication: None
Duration of surgery (mins): 52.8 (± 17.2)
Duration of Anaesthesia (mins): 79.0 (± 19.3)
Monitoring: After intubation, the infusion rate of propofol was adjusted to maintain
adequate depth of anaesthesia, as indicated by clinical signs and haemodynamic changes
Outcomes Accidental awareness
Awareness of recall obtained in recovery room. No details of method used
Not reported in Results section, only in Discussion “Although none of the patients in
the study reported any awareness, awareness can be a risk in patients who receive total
IV anaesthesia with propofol in the event of an infusion pump or IV malfunction”
Identification Country: USA
Setting: University Hospital
Authors name: R Sukhani
Institution: Loyola University Medical Center
Email: NR
Address:Department of Anesthesiology, Loyola University Medical Center,2160 South
First Avenue, Maywood, IL 60153
Aim of study To compare the emetic sequelae and quality of recovery between a group of participants
anaesthetized with propofol alone and a group anaesthetized with propofol plus nitrous
oxide
Notes Sponsorship source: NR. No statement of conflicts
Risk of bias
Bias Authors’ judgement Support for judgement
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Sukhani 1994 (Continued)
Random sequence generation (selection
bias)
Unclear risk Quote: “the patients were assigned ran-
domly to one of the two treatment groups
using a non-blinded study design”
Comment: No details of method of se-
quence generation or allocation conceal-
ment
Allocation concealment (selection bias) Unclear risk Comment: No details of method of se-
quence generation or allocation conceal-
ment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: Study described as unblinded.
Depth of anaesthesia at discretion of anaes-
thetist
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “Intermediate recovery variables
were recorded by recovery room nurses and
the attending anesthesiologist blinded to
anesthetic technique”
Comment: Assume different anaesthesiol-
ogist. Study described as unblinded but not
clear if women were aware of allocation -
but questions asked in recovery room so
unlikely to be important
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: No attrition reported
Selective reporting (reporting bias) Unclear risk Quote: “Although none of the patients in
the study reported any awareness, aware-
ness can be a risk in patients who receive to-
tal IV anesthesia with propofol in the event
of an infusion pump or IV malfunction.”
Comment: Relevant outcome not reported
in the Results section, only mentioned in
the Discussion
Other bias Low risk Comment: None identified
Vanacker 1999
Methods Study design: Randomized controlled trial
Study grouping: Parallel group
Participants Baseline Characteristics
Nitrous oxide-free - A
Number randomized: 30
Number analysed: 30
Age (mean): 50.2 (± 1.7)
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Vanacker 1999 (Continued)
% male: 0
Type of surgery: Breast surgery
Other information: Fentanyl given (mcg/kg/hr): 2.31 (±0.2)
Nitrous oxide-based - A
Number randomized: 30
Number analysed: 30
Age (mean): 48.3 (± 1.9)
% male: 0
Type of surgery: Breast surgery
Other information: Fentanyl given (mcg/kg/hr): 2.65 (± 0.6)
Included criteria: Women scheduled for breast surgery with a duration of 1 - 3 hrs. 18
- 65 yrs, ASA I or II
Excluded criteria: Body weight ≥ 20% outside normal, history of motion sickness or
of PONV, pregnant or breastfeeding, history of alcohol or drug abuse, sensitivity to
narcotics, impaired renal or hepatic function, recent (< 30 days) participation in another
study
Interventions Intervention Characteristics
Nitrous oxide-free - A
Name: Desflurane + air and oxygen FiO 0.33
Induction: Propofol 2 mg/kg vecorunium 0.1 mg/kg
Maintenance: Desflurane + air and oxygen FiO 0.33. Concentration of anaesthetic
given to participants was based on previously determined MAC values and adjusted to
participant needs as clinically indicated with the objective to maintain heart rate and
blood pressure within 20% of baseline values. Mean end-tidal desflurane concentration
5.65 (0.09)%. Additional fentanyl given if signs of inadequate anaesthesia (i.e. move-
ment, swallowing, tearing or salivation) despite changes in inhalation concentration.
Ventilatory settings were adjusted to achieve normocapnea
Recovery: Desflurane was discontinued and participants received 100% oxygen (7 l/min
fresh gas flow)
Other drugs used: Tenoxicam 40 mg IV, administered 5 mins after skin incision
Premedication: Alprazolam 0.5 mg orally 1 - 2 hrs before surgery at discretion of inves-
tigator (anxious or worried participant). Pre-induction dose of fentanyl 2 mcg/kg.
Premed given: 13 (43.3%)
Duration of anaesthetic (mins): 111.5
Nitrous oxide-based - A
Name: Desflurane + N O and oxygen FiO 0.33
Induction: Propofol 2 mg/kg vecorunium 0.1 mg/kg
Maintenance: Desflurane + N O and oxygen FiO 0.33. Concentration of anaesthetic
based on previously determined MAC values and adjusted to participant needs as clini-
cally indicated with the objective to maintain heart rate and blood pressure within 20%
of baseline values. Mean end-tidal desflurane concentration 3.18 (0.07)%. Additional
fentanyl given if signs of inadequate anaesthesia (i.e. movement, swallowing, tearing
or salivation) despite changes in inhalation concentration. Ventilatory settings were ad-
justed to achieve normocapnea
Recovery: At end of surgery, desflurane and N O were discontinued and participants
received 100% oxygen (7 l/min fresh gas flow)
Other drugs used: Tenoxicam 40 mg IV administered 5 mins after skin incision
Premedication: Alprazolam 0.5 mg orally 1 - 2 hrs before surgery at discretion of inves-
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Vanacker 1999 (Continued)
tigator (anxious or worried participant). Pre-induction dose of fentanyl 2 mcg/kg.
Premed given: 12 (40%)
Duration of anaesthetic (mins): 109.7
Monitoring:Concentration of anaesthetic given to participants was based on previously
determined MAC values and adjusted to participant needs as clinically indicated with
the objective to maintain heart rate and blood pressure within 20% of baseline values.
Additional fentanyl given if there were signs of inadequate anaesthesia (i.e. movement,
swallowing, tearing or salivation) despite changes in inhalation concentration
Outcomes Accidental awareness
Assessed 0 - 2 hrs after surgery - asked about recall of intra-operative events or dreams
during anaesthesia. No recall was reported in either group
Identification Country: Belgium
Setting: University Hospital
Authors name: BF Vanacker
Institution: University Hospitals K.U. Leuven
Email: NR
Address:UniversityHospitals K.U. Leuven, Department of Anaesthesiology, Herestraat,
49, B-3000, Leuven, Belgium
Aim of study To evaluate the effect of the combination of desflurane with nitrous oxide versus desflu-
rane alone on postoperative nausea and vomiting in a subgroup of female inpatients
Notes Sponsorship source: NR. No statement re conflict of interest
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: “randomized (performed using
the sealed envelope technique) ”.Nodetails
given of sequence generation
Allocation concealment (selection bias) Low risk Comment: “randomized (performed using
the sealed envelope technique) ”. Alloca-
tion probably concealed
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Comment: No mention of blinding.
Anaesthetist varied inhalation concentra-
tion and fentanyl doses
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Comment: No mention of blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: No reported attrition
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Vanacker 1999 (Continued)
Selective reporting (reporting bias) Low risk Comment: All relevant outcomes described
in Methods reported
Other bias Low risk Comment: None identified
Anaes - anaesthetic
ASA - American Society of Anesthesiologists Physical Status Classification System
BMI - body mass index
CNS - central nervous system
FiO - fraction of inspired oxygen
hr - hour
HR - heart rate
IV - intravenous
kg - kilogram
KPa - kilopascal
MAC - minimum alveolar concentration
mcg - microgram
mg - milligram
mins - minutes
ml - millilitre
ML-AERS - Midlatence Auditor evoked Responses
N O - Nitrous oxide
ng - nanogram
NR - not reported
O - oxygen gas
PACU - paediatric acute care unit
PONV - postoperative nausea and vomiting
surg - surgery
TCI - target controlled infusion
US - ultrasound
yrs - years
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Chowdhury 2014 Different depth of anaesthesia in study groups - full paper
ENIGMA-II Does not measure AAGA
Goto 1997 Wrong intervention - Xenon versus nitrous oxide- sevoflurane Vs nitrous oxide-isoflurane
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(Continued)
Goto 1997a Wrong intervention - Xenon versus nitrous oxide- sevoflurane Vs nitrous oxide-isoflurane
Inada 1999 Different depth of anaesthesia in study groups
Kang 2013 Different depth of anaesthesia in study groups (abstract)
Liu 2014 Different depth of anaesthesia in study groups
Luginbuhl 2005 Wrong intervention -Xenon versus nitrous oxide + desflurane
Nakata 1999 Wrong intervention - sevoflurane with one of three anaesthetics; 1 MAC xenon, 0.7 MAC xenon and 0.7 MAC
nitrous oxide
Ochiai 1999 Wrong intervention - all participants were maintained with nitrous oxide
Rocca 2000 Different depth of anaesthesia in study groups
Ropcke 2001 Wrong intervention - each participant had 2 concentrations of nitrous oxide so those who had none at 1 time
also had another concentration
AAGA - accidental awareness during general anaesthesia
MAC - minimum alveolar concentration
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D A T A A N D A N A L Y S E S
Comparison 1. Nitrous oxide -free vs Nitrous oxide-based
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Accidental awareness 14 Peto Odds Ratio (Peto, Fixed, 95% CI) Totals not selected
1.1 Overall 14 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 In recovery 5 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 24 hours 7 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.0 [0.0, 0.0]
Analysis 1.1. Comparison 1 Nitrous oxide -free vs Nitrous oxide-based, Outcome 1 Accidental awareness.
Review: Nitrous oxide-based versus nitrous oxide-free general anaesthesia and accidental awareness during general anaesthesia in surgical patients
Comparison: 1 Nitrous oxide -free vs Nitrous oxide-based
Outcome: 1 Accidental awareness
Study or subgroup Nitrous oxide-based Nitrous oxide -free
Peto
Odds Ratio
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Overall
Aceto 2002 (1) 0/10 0/10 Not estimable
Aceto 2002 (2) 0/10 0/10 Not estimable
Albertin 2005 (3) 0/27 0/30 Not estimable
Albertin 2005 (4) 0/22 0/23 Not estimable
Arellano 2000 1/307 0/310 7.46 [ 0.15, 376.06 ]
Crawford 1998 0/17 0/18 Not estimable
Dedola 2008 (5) 0/22 0/26 Not estimable
Dedola 2008 (6) 0/25 0/25 Not estimable
ENIGMA 2/1015 0/997 7.27 [ 0.45, 116.26 ]
Girardi 1994 0/25 0/26 Not estimable
Handa 2010 0/60 0/58 Not estimable
Handa Tsutsui 2007 0/24 0/23 Not estimable
Lindekaer 1995 0/21 0/21 Not estimable
0.002 0.1 1 10 500
Favours Nitrous oxide-based Favours Nitrous oxide -free
(Continued . . . )
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(. . . Continued)
Study or subgroup Nitrous oxide-based Nitrous oxide -free
Peto
Odds Ratio
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Ngan Kee 2002 (7) 0/20 0/10 Not estimable
Ngan Kee 2002 (8) 0/20 0/10 Not estimable
Singh 2011 0/41 0/46 Not estimable
Sukhani 1994 0/34 0/36 Not estimable
Vanacker 1999 0/30 0/30 Not estimable
2 In recovery
Crawford 1998 0/17 0/18 Not estimable
Girardi 1994 0/25 0/26 Not estimable
Handa Tsutsui 2007 0/24 0/23 Not estimable
Sukhani 1994 0/34 0/36 Not estimable
Vanacker 1999 0/30 0/30 Not estimable
3 24 hours
Aceto 2002 (9) 0/10 0/10 Not estimable
Aceto 2002 (10) 0/10 0/10 Not estimable
Albertin 2005 (11) 0/22 0/23 Not estimable
Albertin 2005 (12) 0/27 0/30 Not estimable
Dedola 2008 (13) 0/22 0/26 Not estimable
Dedola 2008 (14) 0/25 0/25 Not estimable
Girardi 1994 0/25 0/26 Not estimable
Handa 2010 0/60 0/58 Not estimable
Ngan Kee 2002 (15) 0/20 0/10 Not estimable
Ngan Kee 2002 (16) 0/20 0/10 Not estimable
Singh 2011 0/41 0/46 Not estimable
0.002 0.1 1 10 500
Favours Nitrous oxide-based Favours Nitrous oxide -free
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(1) Sevoflurane with or without nitrous oxide
(2) Isoflurane with or without nitrous oxide
(3) Sevoflurane plus remifentanil 1ng.ml
−1
with or without nitrous oxide
(4) Sevoflurane plus remifentanil 3ng.ml
−1
with or without nitrous oxide
(5) Desflurane plus remifentanil 3ng.ml
−1
with or without nitrous oxide
(6) Desflurane plus remifentanil 1ng.ml
−1
with or without nitrous oxide
(7) Sevoflurane and fraction inspired oxygen (FiO2) at 0.7 with or without nitrous oxide
(8) Sevoflurane and fraction inspired oxygen (FiO2) at 0.5 with or without nitrous oxide
(9) Sevoflurane with or without nitrous oxide
(10) Isoflurane with or without nitrous oxide
(11) Sevoflurane plus remifentanil 1ng.ml
−1
with or without nitrous oxide
(12) Sevoflurane plus remifentanil 3ng.ml
−1
with or without nitrous oxide
(13) Desflurane plus remifentanil 3ng.ml
−1
with or without nitrous oxide
(14) Desflurane plus remifentanil 1ng.ml
−1
with or without nitrous oxide
(15) Sevoflurane and fraction inspired oxygen (FiO2) at 0.7 with or without nitrous oxide
(16) Sevoflurane and fraction inspired oxygen (FiO2) at 0.5 with or without nitrous oxide
A P P E N D I C E S
Appendix 1. Search strategies
Ovid MEDLINE(R) 1946 to July Week 3 2014, Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations July 29, 2014,
Ovid MEDLINE(R) Daily Update July 29, 2014
1 ((randomized controlled trial or controlled clinical trial).pt. or randomi$ed.ab. or placebo.ab. or drug therapy.fs. or randomly.ab. or
trial.ab. or groups.ab.) not (animals not (humans and animals)).sh.
2 exp Intraoperative Complications/
3 exp surgical procedures, operative/
4 (surger* or surgical or intraoper* or postoper* or operat*).mp.
5 or/2-4
6 nitrous oxide.mp. or exp Nitrous Oxide/ or entonox.mp.
7 6 and 5 and 1
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8 6 and 1
9 (anaes* or anes*).mp.
10 exp Anesthesia/
11 or/5,9-10
12 6 and 11 and 1
13 6 and (9 or 10) and 1
Cochrane Search Search Name:nitrous oxide June 14
Date Run:30/07/14 13:10:51.810
Description:
IDSearchHits
#1MeSH descriptor: [Nitrous Oxide] explode all trees
#2nitrous oxide or entonox
#3#1 or #2
#4surger* or surgical or intraoper* or postoper* or operat* or anes* or anes*
#5MeSH descriptor: [Anesthesia] explode all trees
#6MeSH descriptor: [Intraoperative Complications] explode all trees
#7MeSH descriptor: [Surgical Procedures, Operative] explode all trees
#8{or #4-#7}
Database: Embase <1988 to 2014 Week 32>
Search Strategy:
--------------------------------------------------------------------------------
1 exp peroperative complication/ (19525)
2 exp surgery/ (2788966)
3 (surger* or surgical or intraoper* or postoper* or operat*).mp. (2388900)
4 or/1-3 (3544644)
5 (nitrous oxide or entonox).mp. or exp nitrous oxide/ (21319)
6 randomized controlled trial/ or exp “randomized controlled trial (topic)”/ or randomi$ed.ab. or placebo.ab. or randomly.ab. or
trial.ab. or groups.ab. (2181006)
7 and/4-6 (3958)
8 limit 7 to (human and yr=“1994 -Current”) (3206)
***************************
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Appendix 2. Data extraction form from Covidence
Study ID
Identification
Field Value
Sponsorship source
Country
Setting
Comment
Author’s name
Institution
Email
Address
Study design
Field Value
Study Design
Group
Participants
Field Value
Inclusion Criteria
Exclusion Criteria
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(Continued)
Baseline characteristics
Characteristics Nitrous oxide - free - A Nitrous oxide - based -
A
Nitrous oxide - free - B Nitrous oxide-based - B
Number randomized
Number analysed
Age (mean)
% male
Type of surgery
Other information
Intervention characteristics
Characteristics Nitrous oxide - free - A Nitrous oxide -based
Induction
Maintenance
Recovery
Other drugs used
Premedication
Name
Pre-treatment
Field Value
Group Differences
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(Continued)
Appendix 3. Data extraction outcome form from Covidence
Outcomes: Dichotomous
Treatment or comparator: Nitrous oxide - free - A
Outcome
Measure
Af-
ter 48
hours
In re-
covery
24
hours
Overall
n N n N n N n N
Accidental
awareness
Treatment or comparator: Nitrous oxide-based - A
Outcome
Measure
Af-
ter 48
hours
In re-
covery
24
hours
Overall
n N n N n N n N
Accidental
awareness
Treatment or comparator: Nitrous oxide -free - B
Outcome
Measure
Af-
ter 48
hours
In re-
covery
24
hours
Overall
n N n N n N n N
Accidental
awareness
Treatment or comparator: Nitrous oxide-based - B
Outcome
Measure
Af-
ter 48
hours
In re-
covery
24
hours
Overall
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(Continued)
n N n N n N n N
Accidental
awareness
C O N T R I B U T I O N S O F A U T H O R S
Juliet Hockenhull (JH) Amanda Nicholson (AN), Janette Greenhalgh (JG) Tim MCook (TC), Andrew F Smith (AS), Sharon R Lewis
(SL)
Conceiving the review: TC, AS
Co-ordinating the review: AN
Undertaking manual searches: AN
Screening search results: JH, JG, AN.
Organizing retrieval of papers: JH
Screening retrieved papers against inclusion criteria: JH, JG, AN.
Appraising quality of papers: JH, AN
Abstracting data from papers: JH, AN
Data management for the review: JH
Entering data into RevMan (RevMan 5.3): AN, SL, JH
RevMan statistical data: N/A
Other statistical analysis not using RevMan: N/A
Interpretation of data: JH, AN, TC, AS
Statistical inferences: JH, AN, TC, AS
Writing the review: AN, TC, AS, JH
Securing funding for the review: AS
Performing previous work that was the foundation of the present study: TC
Guarantor for the review (one author): JH
Person responsible for reading and checking review before submission: JH
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D E C L A R A T I O N S O F I N T E R E S T
Juliet Hockenhull: none known
Amanda Nicholson: from March to August 2011, AN worked for the Cardiff Research Consortium, which provided research and
consultancy services to the pharmaceutical industry. Cardiff Research Consortium has no connection with AN’s work with Cochrane.
AN’s husband has small direct holdings in several drug and biotech companies as part of a wider balanced share portfolio. All AN’s
contributions to this review were prior to her work with QMedical Technologies Limited, she conducted the work on this review whilst
employed by Liverpool University.
From June 2015 AN has worked for QMedical Technologies Limited, a firm which markets and distributes a range of medical devices.
Q Medical Technologies do not sell any products that promote, or are specific to, nitrous-oxide based anaesthesia.
See Sources of support.
Janette Greenhalgh: none known
Tim M Cook: none known.
Sharon R Lewis: none known.
Andrew F Smith: none known.
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• NIHR Cochrane Collaboration Programme Grant. Enhancing the safety, quality and productivity of perioperative care. Project
Ref: 10/4001/04., UK, Other.
This grant funds the work of AN, AS & SL on this review
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We made the following changes to the protocol (Nicholson 2014):
Authorship:
• The authorship of the review changed, with two additional authors (JH and JG) joining the team. JH became the lead author.
Background
• We added further information regarding the 5th National Audit Project (NAP5) and updated references
• We deleted details of other endpoints due to the removal of the secondary objectives of this review (see later for details)
• We added information on the ENIGMA II study (Myles 2014a)
Objectives
• We have reworded the primary objective from “unintentional intraoperative explicit awareness” to AAGA, as this term is now
more widely used
• We removed the secondary objectives from the review
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The secondary objectives were to assess the effect of general anaesthesia including nitrous oxide on the risk of wakefulness without
recall during anaesthesia and on the results of depth of anaesthesia brain monitoring during surgery. However brain monitoring results
are not equivalent to awareness (this relationship is not established) and we wanted to ensure that the review focused on the clinically
relevant endpoint of accidental awareness.
Types of interventions
• We excluded studies where the depth of anaesthesia were reported as differing between study arms
Since depth of anaesthesia will affect the likelihood of accidental awareness, we excluded studies where we judged the two arms to
have had different depths of anaesthetic. In order to assess this we used the reportedminimum alveolar concentration (MAC) in the
published reports. MAC is the concentration of the vapour in the lungs that is needed to prevent visible movement in 50% of people
in response to a standard surgical stimulus. MAC is used to compare the strengths, or potency, of anaesthetic agents. We assumed that,
broadly, MACs are additive and used this to determine whether the two intervention arms had ’similar depth anaesthetics’.
Types of outcome measures
• We removed secondary outcomes from the review
The secondary outcomes outlined in the protocol included wakefulness and results from instruments used to monitor brain activity.
However, as the secondary objectives of the review were removed the secondary outcomes were not relevant
• We included studies that reported AAGA as a secondary outcome
The inclusion criteria for studies in the published protocol stated that studies must have any of our outcomes as a primary outcome.
During the initial stages of the review we found no studies that reported AAGA as a primary outcome. We did, however, identify studies
that recorded AAGA as one of a number of secondary outcomes, and the quality of these appeared to be adequate. In consultation with
the content editor we amended the protocol so that we included studies which included AAGA as a prespecified outcome, provided all
participants were asked postoperatively about awareness and that the study did not rely on volunteered self report. Awareness did not
need to be the main/primary aim of the study.
This meant that many studies had to be reviewed in full text to ensure that awareness had not been included as an outcome.
Search methods for identification of studies
The above changes meant that the searches we ran were modified, dropping the requirement for awareness or other outcomes. In order
to limit the number of studies to be reviewed in full text, we restricted the search to studies published in or after 1994. We did not
search CINAHL or ISI Web of Science.
Data collection and analysis
• Due to changes in authorship, different authors were involved in the data collection and analysis
• Due to the inclusion of AAGA as a study’s secondary outcome, many studies could not be excluded at screening. We therefore
reviewed all trials with eligible design, population, intervention and comparison groups in full text
• Instead of using a paper extraction form we used Covidence for review of full-text articles and for data extraction and quality
assessment. Forms used as in Appendix 2; Appendix 3
• We did not contact any authors for further information, due to the volume of full texts reviewed
Assessment of risk of bias in included studies
• We expanded on details of the criteria for assessing risk of bias
• We removed details of risk of bias for brain monitoring studies
• We restricted the assessment of detection bias to the blinding of outcome assessors and participants, as there were insufficient
details on the method of ascertainment of outcome on which to assess studies
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Measures of treatment effect
• As the review now included only one outcome (AAGA) which is dichotomous, we deleted details of other possible reporting of
outcomes
Unit of analysis issues
• We did not expect eligible studies to include more than one comparison; however, four studies did so and we therefore added
details on how we managed this
Dealing with missing data
• We did not contact any authors for further information due to the volume of full texts reviewed
Assessment of reporting biases
• We did not contact any authors for further information due to the volume of full texts reviewed
Summary of findings
• As there were no secondary outcomes included in the review, we applied the GRADE criteria only to AAGA
• Due to changes in authorship, different authors were involved in the application of GRADE
Many of these changes to the protocol will not have biased the review process; however, several may have and should be discussed.
The most substantial changes to the protocol were the removal of the secondary objectives and therefore the secondary outcomes, and
the inclusion of studies reporting AAGA as a secondary outcome. This decision was based on our findings at the start of the review
process and on discussion with clinicians and the content editor. We found no studies on wakefulness as a primary outcome and the
clinical assertion was that brain monitoring results are not equivalent to awareness. These changes may have had an impact on the bias
in the review, as these decisions were made after the initial searches. The inclusion of studies where AAGAwas a secondary outcome may
also have impacted on the risk of bias of the review. To accurately identify all studies which included AAGA as a secondary outcome,
we would have needed to contact all study authors. However the sheer volume of studies meant this was impractical and we relied
upon the reporting of secondary outcomes in the Methods section of papers, which we reviewed in full. Therefore some studies that
did measure AAGA as a predetermined secondary outcome may have been excluded from the review if the outcome was not stated in
the study publication.
Finally in order to limit the number of studies to be reviewed in full text, we restricted the search to studies published in or after
1994, and did not search CINAHL or ISI Web of Science. This may have biased the review process. However, as clinical practices have
changed significantly in the last 20 years we judged this to be a reasonable cut-off.
I N D E X T E R M S
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Medical Subject Headings (MeSH)
∗Anesthesia, General; ∗Anesthetics, Inhalation; ∗Intraoperative Awareness; ∗Mental Recall; ∗Nitrous Oxide; ∗Surgical Procedures,
Operative; Randomized Controlled Trials as Topic
MeSH check words
Adult; Child; Humans; Middle Aged
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